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Abstract 
Adenoviruses (Ad) are able to interact with a number of proteins involved in the cellular 
response to DNA damage, in order to prevent concatamerisation of the viral genome and 
inhibition of viral replication. It is becoming increasingly apparent that the adenoviral E3 
ligase complex (comprised of E1B-55K and E4 adenoviral proteins) is able to target a number 
of cellular DNA damage response proteins for proteasomal degradation. Here we show that 
the RecQ helicase, BLM, is degraded during infection with adenovirus serotypes 4, 5 and 12. 
In addition, we were able to show, through the use of mutant viruses, that the degradation of 
BLM is dependent on E1B-55K and E4 activity during Ad5 infection, a mechanism which is 
suggested to occur during both Ad4 and Ad12 infection. Using co-immunoprecipitation and 
GST pull-down assays, we were able to confirm E1B-55K and BLM interactions in vivo and 
in vitro during Ad5 and Ad12 infection, whilst additionally suggesting that E1B-55K binds to 
BLM via a region similar to the known E1B-55K binding site on p53. Finally, we found that 
the degradation of BLM during adenovirus infection was dependent on proteasome activity, 
establishing that a component of the E3 ligase complex, Cullin 4B, may be responsible for the 
degradation of BLM during adenovirus infection. These observations show that another 
component involved in DNA end resectioning, besides MRN, is a target for viral degradation 
by the adenovirus family. 
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Chapter One: 
 
Introduction 
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1.1 Adenovirus 
The adenovirus (Ad) family are a group of small DNA tumour viruses, with over 50 different 
serotypes (classified into groups A to G) identified to date (Table 1.1). The adenovirus family 
has been studied extensively and is frequently used to study mechanisms of viral replication 
and cellular transformation (Weitzman and Ornelles, 2005). Whilst adenovirus infection has 
not been linked with the development of any human cancers, infection with group A viruses, 
and particularly adenovirus serotype 12 (Ad12), has been associated with tumour 
development in new-born mice (Trentin et al., 1962). In addition, further evidence for the 
possible oncogenicity of adenoviruses comes from studies showing that most adenovirus 
serotypes are able to transform primary rodent cells in vitro (McBride et al., 1964; Freeman et 
al., 1967).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1: Adenovirus Serotypes Classified to Date. The adenovirus serotypes 
identified to date are indicated, classified into groups A to G. Virus serotypes are 
considered to be most oncogenic the higher up in the table they appear (adenovirus 
serotypes in group A are considered to have the most oncogenic potential). 
Adenovirus serotypes used in this study are highlighted in red. 
 
Group Serotype 
A 12, 18, 31 
B1 3, 7, 16, 21, 50 
B2 11, 14, 34, 35, 55 
C 1, 2, 5, 6 
D 
8, 9, 10, 13, 15, 17, 19, 22-30, 32, 33, 36-39, 42-49, 51, 53, 
54 
E 4 
F 40, 41 
G 52 
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1.2 The Adenovirus E1A and E1B-55K Proteins 
The adenovirus genome contains 6 different early genes (E1A, E1B, E2A, E2B, E3 and E4), 
and 5 late genes (L1, L2, L3, L4 and L5) (Figure 1.1) (Weitzman and Ornelles, 2005). 
Expression of E1A is necessary for the immortalisation of primary rodent cells in vitro, 
however, in order to completely transform these cells, expression of another oncogene, for 
example, E1B, is required (Van Den Elsen et al., 1983). E1A is the first viral protein to be 
expressed following infection and its expression is necessary for the activation of 
transcription of the other early viral genes. In addition to its function as a transcriptional 
activator, E1A also associates with a number of cellular proteins involved in gene expression 
and cell growth, with the aim to force cells into S-phase, in order to effectively replicate the 
viral genome. E1A interactions include association with the transcriptional co-activators 
p300/CREB-binding protein (CBP) and p300/CBP-associated factor (PCAF), the 
transcriptional co-repressor C-terminal binding protein (CtBP), and other proteins that 
regulate the cell-cycle such as p400, TRAF and TNF receptor-associated protein (TTRAP), 
the tumour suppressor retinoblastoma protein (pRB) and related proteins p107 and p130, 
dual-specificity Yak1-related kinases (DYRKs), and the cyclin-dependent kinase inhibitors 
(CKIs) p21 and p27 (Frisch and Mymryk., 2002; Pelka et al., 2008).  
 
The E1B-55K protein is able to cooperate with E1A to stably transform cells. The E1B 
protein has early viral functions including the inhibition of the DNA damage response, and 
late viral functions such as the inhibition of cellular mRNA export and the promotion of viral 
mRNA export. The interaction between E1B-55K and the E4 open reading frame 6 (E4orf6) 
protein is thought to be essential for most of the functions of the E1B-55K protein. For  
 
0 5 10 15 20 25 30 35 
kb 
E1A E1B 
E2B E2A 
E3 
E4 
L1 L2 L3 L4 L5 
Figure 1.1: Adenovirus Genome Organisation.  Schematic to outline the 
organisation of the adenovirus genome. Early adenovirus transcripts are 
indicated in red, late adenovirus transcripts are indicated in blue. Direction 
of the arrows represent the direction of transcription (modified from Russell, 
2000). 
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example, the localisation of E1B-55K to the nucleus and viral replication centres appears to 
be dependent on E4orf6 association (Ornelles and Shenk, 1991; Dobbelstein et al, 1997). 
E1B-55K, together with E4orf6, is responsible for the degradation of proteins which act to 
inhibit viral replication. This is achieved, in the case of Ad5, by E1B-55K and E4orf6, along 
with Cullin 5 (Cul5), RING-box 1 (Rbx1) and elongins B and C, together forming an E3 
ubiquitin ligase complex which is able to target p53, Mre11-Rad50-Nbs1 (MRN) and DNA 
ligase IV for degradation (Querido et al, 2001; Stracker et al, 2002; Baker et al, 2007). Late 
functions of the E1B-55K protein include the inhibition of cellular mRNA export and 
promotion of viral mRNA export from the nucleus, which may also be dependent on the 
degradation of cellular proteins (Dobbelstein et al, 1997; Woo and Berk, 2007).  
 
1.3 The DNA Damage Response 
Cells have complex mechanisms to sense and respond to various forms of DNA damage. The 
key regulators in the response to DNA damage are considered to the phosphatidylinositol 3 
(PI3) kinase family members ataxia telangiectasia mutated (ATM) and ataxia telangiectasia 
and RAD3 related (ATR) kinases. The ATM kinase responds to double-strand breaks induced 
by ionising radiation (IR) and cellular stress, and the ATR kinase responds to single-stranded 
lesions induced by ultra-violet (UV) radiation and stalled replication forks (Khanna and 
Jackson, 2001).  
 
In response to single-strand breaks induced by UV radiation and stalled replication forks, 
single-stranded DNA (ssDNA) is coated by replication protein A (RPA) to form a ssDNA-
RPA complex. ATR interacting protein (ATRIP) is responsible for sensing the ssDNA-RPA 
complex and recruiting ATR to the site of the single-stranded lesion (Zou and Elledge, 2003).  
ssDNA 
UV IR 
DNA Damage 
ATM 
DSBs 
RPA RPA RPA 
RPA RPA RPA 
ATR ATRIP 
UV 
IR 
Chk2 Chk1 
Rad50 
Mre11 NBS1 
BLM 
H2AX SMC1 
BRCA1 
Cell Cycle 
Arrest 
FANCD2 
p53 
Apoptosis Repair 
Figure 1.2: The DNA Damage Response Signalling Pathways. In response to single-strand 
breaks induced by IR (or collapsed replication forks), ssDNA is bound by RPA, which 
ultimately results in the association of ATRIP with ATR, leading to its activation. The activated 
ATR kinase is then able to phosphorylate and subsequently activate the DNA damage proteins 
indicated. The MRN complex is able to sense double-strand breaks induced by ionising 
radiation (or cellular stress). The MRN complex is then able to activate ATM, leading to the 
phosphorylation and subsequent activation of proteins involved in cell-cycle arrest, DNA 
repair and apoptosis (Zhou and Bartek, 2004). 
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The ssDNA-RPA complex also induces the binding of the RAD9-RAD1-HUS1 complex to 
the lesion via its association with RAD17-replication factor C 2 (RFC2) clamp loader 
complex (Yang and Zou, 2006). Association of the RAD9-RAD1-HUS1 complex with the 
single-stranded lesion causes topoisomerase II binding protein 1 (TOPBP1) recruitment and 
the subsequent activation of ATR (Kumagai et al., 2006). ATR is then able to phosphorylate 
downstream targets such as Chk1, BRCA1, H2AX and BLM, ultimately resulting in cell-
cycle arrest and the stabilisation of stalled replication forks (Figure 1.2) (reviewed in Zhou 
and Bartek, 2004). 
 
In response to double-strand breaks, the double-strand break sensor, the Mre11-Rad50-Nbs1 
(MRN) complex, is recruited to the sites of damage where it binds to, and activates ATM, 
stimulating its autophosphorylation (Lee and Paul, 2005). ATM is then able to phosphorylate 
H2AX, which subsequently interacts with mediator of DNA damage checkpoint 1 (MDC1). 
H2AX and MDC1 recruit various DNA damage proteins to the site of the double-strand 
break. ATM then phosphorylates the recruited DNA damage proteins, including Chk2, p53, 
FANCD2, SMC1, BRCA1, H2AX, and BLM, ultimately leading to cell-cycle arrest and 
double-strand break repair (Figure 1.2) (Zhou and Bartek, 2004; Cimprich and Cortez, 2008).  
 
1.4 The DNA Damage Response and Adenovirus Infection 
During adenovirus infection, a relatively large amount of double-stranded viral DNA is 
produced which is probably recognised by the cell as damaged cellular DNA. Processing of 
this viral DNA by the cellular DNA damage response would be catastrophic for the virus, 
resulting in joining of DNA ends and the formation of viral concatemers (Weiden and 
Ginsberg, 1994). Mounting evidence now suggests that adenoviruses target components of the 
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DNA damage response in order to effectively replicate the viral genome (Lilley and 
Weitzman, 2007). In addition, adenoviruses are also able to inactivate critical components of 
cell-cycle checkpoint response such as p53, in order to avoid cell-cycle arrest or apoptosis in 
the host cell (Querido et al., 2001). Upon infection with adenovirus, ATM activation in 
response to linear double-stranded viral DNA is limited due to E1B-55K/E4orf6 degrading 
the double-strand break sensor, MRN (Carson et al., 2003; Stracker et al., 2002). In addition, 
the E4orf3 protein is able to relocalise the Mre11 to aggresomes and nuclear tracks, 
sequestering it so that ATM repair pathway cannot be activated (Evans and Hearing, 2005; 
Liu et al., 2005; Araujo et al., 2005). Non-homologous end joining (NHEJ) repair is prevented 
through its association and inhibition of DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) activity and through the degradation of DNA ligase IV by the E1B-55K/E4orf6 
E3 ligase (Boyer et al., 1999; Baker et al., 2007). One study suggested that during adenovirus 
infection, ATR, RPA, ATRIP and TOPBP1 all localise to viral replication centres, however 
no ATR signalling response is observed throughout infection (Evans and Hearing, 2005). 
More recent evidence suggests that infection with adenovirus serotypes 5 and 12 have been 
shown to activate the ATR signalling pathways during late stages of infection in an E1B-55K-
associated protein 5 (E1B-AP5)-dependent fashion (Blackford et al., 2008).  
 
1.5 Double-Stranded DNA Repair Pathways 
Double-strand break repair can be split into two categories; NHEJ and homologous 
recombination repair (HRR). Whether double-strand breaks are repaired by NHEJ and HRR is 
dependent on phase of the cell cycle and the DNA template available. NHEJ involves the 
Ku70/Ku80 protein hetero-dimer binding to the site of the double-strand break and recruiting 
DNA-PKcs. Binding of DNA-PKcs to the site of the double-strand break results in DNA 
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ligase IV, Artemis, XRCC4 and XRCC-like factor (XLF) recruitment to the sites of the 
double-strand break. Following auto-phosphorylation of DNA-PKcs, DNA-PKcs dissociates 
from the DNA and the double-strand break repair proteins are able to repair the double-strand 
break (Shrivastav et al., 2008). In contrast, HRR involves the resection of DNA ends by the 
MRN complex to expose ssDNA. ssDNA is then coated by RPA which subsequently recruits 
the recombinase Rad51. Rad51 forms a nucleoprotein filament with the ssDNA, and with the 
guidance of Rad54, invades the homologous region of the complementary sister strand, 
ultimately resulting in the formation of displacement-loops (D-loops) and Holliday junctions. 
DNA polymerase is then able to synthesise a new DNA strand and is ligated by DNA ligase 
to repair the double-strand break (Shrivastav et al., 2008).  
 
1.6 The RecQ Family of DNA Helicases 
Although HRR is a critical pathway in the maintenance of genome stability, it is also a 
requirement that excessive HRR is prevented, in order to avoid recombination events which 
could result in deleterious genome rearrangements. RecQ helicases are a family of DNA 
helicases which are thought to possess both pro-recombinase and anti-recombinase activities, 
the latter preventing excessive HRR and deleterious genome rearrangements (Chu and 
Hickson, 2009). RecQ helicases are able to translocate along ssDNA in the 3’ to 5’ direction, 
unwinding DNA via disruption of hydrogen bonds which are essential to hold duplex DNA 
together. In contrast to other helicases, RecQ helicases seem to have an affinity for 
recombination intermediates, including D-loops and both single and double Holliday 
junctions (Ouyang et al., 2008). In addition, RecQ helicases also seem to be able to bind to 
replication forks. In humans, the RecQ helicases include RecQL1, RecQL4, RecQL5, BLM 
and WRN, with mutations in RecQL4, BLM and WRN leading to the genetic instability 
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syndromes Rothmund-Thomson syndrome (RTS), Bloom syndrome (BS) and Werner 
syndrome (WS) respectively (Chu and Hickson, 2009).  
 
1.7 Bloom Syndrome and the BLM Protein 
BS is an extremely rare, autosomal recessive disease, with approximately only 240 cases 
identified worldwide. Characteristics of patients with BS include a short stature, hyper- or 
hypo-pigmentation, immune-deficiencies, sensitivity to the sun, fertility problems, defects in 
metabolism, and most significantly, predisposition to all types of cancer (Ouyang et al., 
2008). Genomic instability is a characteristic of patients with BS, due to the loss of BLM and 
subsequent loss of anti-recombination activity. Deficiency in this anti-recombinase activity 
results in increased HRR and increased sister chromatid exchange by up to ten-fold compared 
to sister chromatid exchange in the normal population. Patients with BS have many 
abnormalities at the molecular and chromosome level, including excessive chromatid breaks, 
anaphase-bridges, chromosomal rearrangements and deletions, all of which resulting in a high 
incidence of genetic mutations and genetic instability (Payne and Hickson, 2009). 
 
As far as is known, mutations in BLM in BS patients are limited to mutations leading to 
premature protein translation termination, or amino acid substitutions in the helicase domain 
of BLM which result in loss of helicase activity (Neff et al., 1999; German et al., 2007). In 
normal circumstances, BLM resides in the nucleus in structures known as promyelocytic 
leukemic (PML) nuclear bodies (N.B. These structures also contain other proteins involved in 
DNA repair including p53, the MRN complex and Topoisomerase 3α). In response to 
treatment with DNA damaging agents, BLM localises to DNA repair foci, where it co-
localises with γH2AX, suggesting that BLM is involved in the early DNA damage response. 
BLM stimulates 
exonuclease 1 
activity promoting 
resection 
BLM interacts 
with Rad54, 
upregulating its 
activity and 
promoting strand 
invasion 
BLM interacts 
with Top3α to 
resolve Holliday 
junctions 
BLM interacts with 
Rad51, inhibiting 
polymerisation and 
nucleofilament 
formation 
Pro-recombinase 
roles of BLM 
Anti-recombinase 
roles of BLM 
Figure 1.3 Pro-recombinase and Anti-recombinase Roles of BLM During HRR. 
The pro-recombinase roles of BLM during HRR are noted to the left-hand side of the 
diagram, whilst the anti-recombinase roles are noted to the right. Pro-recombinase 
roles of BLM include the stimulation of exonuclease 1 activity promoting resection of 
dsDNA to ssDNA, the upregulation of Rad54 activity to promote strand invasion and 
the interaction with Top3α to resolve Holliday junctions. Anti-recombinase roles of 
BLM include the inhibition of nucleofilament formation via BLM interactions with 
Rad51. HRR, homologous recombination repair; dsDNA, double-stranded DNA; 
ssDNA, single-stranded DNA; HJ, Holliday junctions; DSBR, double-strand break 
repair (modified from Sung and Klein, 2006). 
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Classically it is thought that BLM functions as an anti-recombination helicase, since 
mutations in BLM lead to an increase in sister chromatid exchanges and chromosomal 
abnormalities. Additional evidence for the anti-recombinase role of BLM includes evidence 
that BLM interacts with the recombinase Rad51, and subsequently inhibits Rad51 
polymerisation, preventing nucleofilament formation and HRR (Figure 1.3) (Bugreev et al., 
2007). Interestingly, recent evidence suggests that BLM has pro-recombinogenic roles (Figure 
1.3). BLM is able to associate with Topoisomerase 3α, and this complex is recruited to double 
Holliday junctions by BLAP75/RMI1 where it is able to resolve them, promoting HRR (Wu 
et al., 2006; Raynard et al., 2006). This is advantageous since convergence of double Holliday 
junctions by BLM eliminates the crossing-over event of conventional Holliday junction 
resolution during HRR, limiting the extent of sister chromatid exchanges. However, this 
observation suggests that BLM is involved in later stages of HRR, and fails to explain why 
BLM colocalises with γH2AX at DNA damage foci, and so additional roles for BLM are 
likely. BLM has also been shown to interact with the pro-recombinase Rad54, up-regulating 
its activity and subsequently promoting HRR (Srivastava et al., 2009). In addition, BLM 
interacts with Exonuclease 1, stimulating its activity and the subsequent resection of DNA to 
form ssDNA (Nimonkar et al., 2008; Gravel et al., 2008). One study also suggests BLM 
processes stalled replication forks by stimulating fork regression, so that replication can be 
restarted (Ralf et al., 2006).   
 
1.8 BLM and Adenovirus Infection 
Mass spectrometric analysis of adenoviral E1B-55K interacting proteins revealed BLM as a 
potential interacting partner (Forrester, unpublished data 2010). Subsequent to this finding, 
our laboratory investigated, via Western blotting, BLM protein levels during adenovirus 
infection. Preliminary results from these investigations suggested that BLM was degraded in 
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response to adenovirus infection, suggesting a novel protein that adenovirus is able to 
degrade, along with p53, Mre11 and DNA ligase VI (Querido et al., 2001; Stracker et al., 
2002; Baker et al., 2007) (Section 1.4). 
 
1.9 Aims 
Based on the preliminary data obtained from our laboratory, the principle aim of this study is 
to establish the relationship of adenoviruses to the DNA damage response protein BLM. In 
order to determine this, a number of objectives will be addressed: 
 
1. To confirm preliminary findings that adenovirus serotypes are able to degrade the 
RecQ helicase, BLM 
2. To determine which adenoviral proteins are responsible for the degradation of BLM 
3. To confirm the importance of the identified viral protein(s) using: 
a) Co-immunoprecipitation assays to confirm in-vivo viral protein-BLM 
interactions 
b)  GST pull-down assays to confirm in-vitro viral protein-BLM interactions 
4. To determine the mechanism by which adenoviruses degrade BLM by: 
a) Using the proteasome inhibitor, MG132 to inhibit proteasome activity to 
establish whether the degradation of BLM is dependent on the proteasome 
b) Using small interfering RNAs (siRNAs) to knock-down Cullin gene-expression 
to establish the E3 ligase involved in BLM degradation. 
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Chapter Two: 
 
Materials and Methods 
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2. Materials and Methods 
2.1 Tissue Culture Techniques 
2.1.1 Maintenance of Human Cell Lines 
Cell lines used in this study were maintained in a 5% CO2/95% O2 incubator at 37°C (Table 
2.1). All cell lines were sustained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma), 
containing 7% v/v foetal calf serum (FCS) (PAA Laboratories). 
 
 
 
Table 2.1 Human Cell Lines used in this Study. The human cell lines used throughout the 
duration of this study are indicated, along with ATCC numbers and any additional information. 
Cell line  ATCC number Information 
HeLa CCL-2.2 Human cervival adenoma cell line expressing HPV-18 
    (Human Papilloma Virus) transforming genes 
Ad5E1HEK293 CRL-1573 Human adenovirus type 5 transformed human embryo 
    kidney cell line 
Ad5E1HER911 N/A Human adenovirus type 5 transformed human embryo 
    retinoblast cell line 
Ad12E1HER2 N/A Human adenovirus type 12 transformed human embryo 
    retinoblast cell line 
Ad12E1HER10 N/A Human adenovirus type 12 transformed human embryo 
    retinoblast cell line 
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2.1.2 Human Cell Culture 
In order to passage adherent cell lines, cells were washed twice with 0.15M saline (Sigma), 
trypsinised using 5mls of 0.05% trypsin-ethylenediaminetetraacetic acid (EDTA) (Invitrogen) 
and incubated at 37°C until cells had lost adherence to the tissue culture dish. After cells had 
come off the dish, 10mls of DMEM with 7% FCS was added to inactivate trypsin activity. 
Following inactivation, cells were centrifuged at 1,200 revolutions per minute (rpm) at room 
temperature for 4 minutes, resuspended in DMEM with 7% FCS to wash and centrifuged 
again. Following the wash, cells were resuspended in DMEM with 7% FCS and replated at 
the required density.  
 
2.1.3 Viral Infections 
HeLa cells, grown to 80% confluency on 6cm dishes, were infected with adenovirus serotypes 
(Table 2.2) diluted in approximately 200μl DMEM (no FCS), at an infectivity level of 20 
particle forming units (pfu)/cell and left for 2 hours in a 37°C incubator. Following infection, 
adenovirus-containing medium was removed and 5mls of DMEM with 7% FCS added and 
incubated at 37°C until required.  
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2.2 Cell Biology Techniques 
2.2.1 Knock-down of Gene Expression using Small-Interfering RNAs (siRNAs) 
24 hours prior to infection, expression of various genes was silenced using 7.5μl of 40mM of 
siRNA (Table 2.3) in 20μl of oligofectamine (Invitrogen), which was added to 1.5ml of 
optimem (Invitrogen) and left to incubate for 30 minutes at room temperature.  Following 
incubation, siRNA mix was added to HeLa cells grown to a confluency of approximately 33% 
and left for 6 hours in a humidified incubator at 37°C. Following the 6 hour incubation 
period, siRNA mix was removed from the cells and replaced with DMEM with 7% FCS. 
Table 2.2 Adenovirus Serotypes and Mutants used in this Study. The adenovirus serotypes 
and mutants used throughout this study and their sources are indicated  
Name Information Source 
Ad3 Adenovirus serotype 3 Professor J. S. Mymryk 
Ad4 Adenovirus serotype 4 Professor J. S. Mymryk 
Ad5 Adenovirus serotype 5 Professor J. S. Mymryk 
Ad7 Adenovirus serotype 7 Professor J. S. Mymryk 
Ad9 Adenovirus serotype 9 Professor J. S. Mymryk 
Ad11 Adenovirus serotype 11 Professor J. S. Mymryk 
Ad12 Adenovirus serotype 12 Professor J. S. Mymryk 
Ad5dl1520 Ad5E1B- mutant Baker and Berk, 1987 
Ad5dl355 Ad5E4orf6- mutant  Dr Keith Leppard 
Ad12dl620 Ad12E1B- mutant Byrd et al., 1987 
h5pm4155 Ad5E4orf6- E4orf3- mutant Professor Thomas Dobner 
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2.2.2 Exposure of Adherent Cell Lines to the Proteasome Inhibitor MG132 
Infected HeLa’s grown in 6cm dishes were treated with 10 μM of the proteasome inhibitor N-
(benzyloxycarbonyl)leucinylleucinylleucinal (MG132) (Sigma) 2 hours post-infection in 
DMEM with 7% FCS and incubated at 37°C until required. 
 
Table 2.3 siRNAs used in this Study.  The siRNAs used to knock-down the expression of various 
genes in this study are shown. The target protein, siRNA type, sense sequence and source are indicated. 
 
Target protein siRNA Sense sequence Source 
Non-silencing  AllStars Proprietary  Qiagen 
CUL2 SMARTpool 5' GGAAGUGCAUGGUAAAUUU 3'  Dharmacon 
    5' CAUCCAAGUUCAUAUACUA 3'   
    5' GCAGAAAGACACACCACAA 3'   
    5' UGGUUUACCUCAUAUGAUU 3'   
CUL4A s16045 5' GGUUUAUCCACGGUAAAGAtt 3' Ambion 
CUL4B s16044 5' GAAGCUAUUCAGAAUAGUtt 3' Ambion 
CUL5 SMARTpool 5' GACACGACGUCUUAUAUUA 3'    Dharmacon 
    5' GCAAAUAGAGUGGCUAAUA 3'   
    5' UAAACAAGCUUGCUAGAAU 3'   
    5' CGUCUAAUCUGUUAAAGAA 3'   
CUL7 s18991 5' CCACUUUUGAGCAUUAUUAtt 3' Ambion 
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2.3 Protein Chemistry Techniques 
2.3.1 Harvesting Human Adherent Cells 
Cells were typically harvested by removing media, washing twice in cold 0.15M saline and 
scraping cells in 400μl of Urea-Tris-Bicine (UTB) lysis buffer (9M Urea (Sigma), 150mM β-
mercaptoethanol (Sigma), 50mM Tris/hydrochloric acid (HCl) (pH 7.5) (Fisher Scientific)). 
Cell scrapings were then pooled into 1.5ml microfuge tubes, sonicated twice to disrupt cell 
membranes and DNA and centrifuged at 13,000 rpm for 15 minutes to clear the lysate. 
Following the spin, the supernatant was retained and the protein concentration of the lysate 
was determined (Section 2.3.2). Cell lysates were stored at -80°C until required.  
 
For harvesting cells for use in Glutathione S-Transferase (GST) pull-down or co-
immunoprecipitation assays, cell lines were harvested by washing twice in ice-cold 0.15M 
saline. In the second saline wash, cells were scraped, pooled into 15ml Falcon tubes and 
centrifuged at 2,000 rpm, 4°C for 5 minutes. Cells were then washed in 0.15M saline a further 
two times, centrifuging at 2,000 rpm, 4°C for 5 minutes each time. Following the final wash, 
cells were lysed in NETN (0.5% NP-40 (Sigma), 150mM NaCl (Sigma), 50mM Tris pH 7.5, 
0.5mM EDTA (Sigma)) (typically 500μl of buffer per dish harvested). Cell lysates were then 
homogenised using a Wheaton-Dounce hand homogeniser and centrifuged at 3,000rpm, 4°C 
for 5 minutes, the supernatant was centrifuged again at 13,000 rpm, 4°C for 15 minutes. 
Finally, the supernatant was centrifuged once more at 45,000 rpm, 4°C for 30 minutes and the 
supernatant retained.  
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2.3.2 Determination of Protein Concentration of Cell Lysates 
Protein concentrations of cell lysates were determined against a standard curve produced 
using known concentrations of bovine serum albumin (BSA) (Sigma) in 200μl of Bio-Rad 
Protein reagent (Bio-Rad Laboratories) which was diluted 1:5 with sterile water. 5μl of cell 
lysate was diluted in 45μl of sterile water, and 10μl of this diluted cell lysate was added to 
200μl of Bio-Rad reagent diluted 1:5 with sterile water. Protein concentration determination 
of cell lysates was repeated four times to improve accuracy. Protein concentrations were read 
using a microplate reader (Bio-Rad model 680) at 595nm wavelength.  
 
2.3.3 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
In order to separate proteins based upon their molecular size, 6-12% polyacrylamide gels 
were made in a total volume of 50mls consisting of 30% w/v acrylamide (37:5:1 BIS-
acrylamide) (Severn Biotech), 0.1% SDS (Severn Biotech), 0.1M Tris (Melford)/ 0.1M Bicine 
(pH 8.3) (Severn Biotech), 0.6% ammonium persulphate (APS) (Sigma) and 0.3% N, N, N’, 
N’-Tetramethylethylenediamine (TEMED) (Severn Biotech). Gels were poured into pre-made 
gel chambers, and well-forming combs were immediately added and the gel was left to 
polymerise. After polymerisation, combs were removed and the polyacrylamide gel was 
washed twice in deionised water, wells were filled with running buffer (0.1M Tris/ 0.1M 
Bicine (pH 8.3) and 0.1% w/v SDS). Cell lysate, GST pull-down and co-immunoprecipitation 
samples were prepared for running on polyacrylamide gels by adding an equal amount of 
Laemmli sample buffer (25% v/v glycerol (BDH Laboratories), 5% β-mercaptoethanol, 2% 
w/v SDS, 0.01% w/v bromophenol blue (BDH Laboratories) and 65mM Tris (pH 6.8)). Once 
Laemmli sample buffer had been added, samples were heated to 80°C for 5 minutes, 
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centrifuged at 13,000 rpm for 1 minute, and loaded onto the polyacrylamide gels along with a 
molecular weight marker for reference at 10-15mA overnight.  
 
2.3.4 Visualisation of Proteins Separated by SDS-PAGE 
Proteins separated by SDS-PAGE were assessed for protein quality by staining the 
polyacrylamide gels for 30 minutes in 0.1% w/v Coomassie brilliant blue R-250 (Sigma) in 
25% methanol (Sigma), 10% acetic acid (Fisher Scientific). After staining, polyacrylamide 
gels were destained in rapid Coomassie destain (acetic acid /methanol/ water (1:3:6 v/v)) 
overnight, and assessed after sufficient destaining.  
 
2.3.5 Visualisation of Proteins on Nitrocellulose Membranes 
Proteins transferred onto nitrocellulose membranes were visualised by staining with Ponceau-
S Stain consisting of 0.1% Ponceau-S (Sigma) and 3% trichloroacetic acid (TCA) (BDH 
Laboratories) for 30 seconds. Nitrocellulose membranes were then washed three times with 
deionised water to visualise proteins, and washed in TBST Tris-Buffered Saline Tween-80 
(TBST) (1% Tween-80 (Sigma), 0.15M NaCl (Sigma), 50mM Tris, HCl pH 7.4 (Fisher 
Scientific)) to remove the remaining stain.  
 
2.3.6 GST Pull-Down Assay 
To assess direct in-vitro protein-protein interactions, GST pull-down assays were performed. 
Ad5E1HEK293, Ad5E1HER911, Ad12E1HER2 and Ad12E1HER10 cell lysates (containing 
10mg protein) were prepared as in Section 2.3.1 and incubated with 25μg GST-fusion 
proteins (Table 2.4) and left rotating at 4°C. After 3 hours, 25μl of packed glutathione-
agarose beads (Sigma) were incubated for 1 hour at 4°C in order to isolate protein-protein 
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complexes. Following this incubation, samples were centrifuged at 3,000 rpm, 4°C for 1 
minute and supernatant was discarded. Samples were then washed 4 times in NETN buffer, 
centrifuging at 3,000 rpm, 4°C for 1 minute between each wash. Finally, samples were 
washed with buffer B (2mM EDTA (Sigma) in PBS), any residual buffer was removed and 
60μl of 25mM glutathione pH 8.2 (BDH Laboratories) was added and left to incubate for 1 
hour at 4°C. Following this incubation, samples were centrifuged at 3,000 rpm, 4°C for 1 
minute and the supernatant retained in a fresh microfuge tube. 30μl of glutathione was again 
added to the beads and incubated at 4°C for a further 30 minutes. After 30 minutes, samples 
were centrifuged at 3,000 rpm, 4°C for 1 minute and supernatant pooled with the previous 
supernatant. 25μl of Laemmli sample buffer was added to the samples, heated to 80°C for 5 
minutes, centrifuged at 13,000 rpm for 1 minute and loaded onto 10% polyacrylamide gels 
along with 50μl of cell lysate as a control and resolved by SDS-PAGE (Section 2.3.3). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4 GST-Fusion Proteins used in this Study. The GST-fusion proteins used in this study 
are indicated, along with the amino acids these fusion proteins incorporate and the source.   
GST-fusion protein Incorporating Source 
GST-BLM WT fragment BLM wild-type fragment aa 1-1417 Produced in this study 
GST-BLM fragment 1 BLM fragment aa 1-212 Produced in this study 
GST-BLM fragment 2 BLM fragment aa 191-660 Produced in this study 
GST-BLM fragment 3 BLM fragment aa 621-1041 Produced in this study 
GST-BLM fragment 4 BLM fragment aa 1001-1417 Produced in this study 
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2.4 Immunological Techniques 
2.4.1 Western Blotting 
Following separation of proteins by SDS-PAGE, proteins were transferred onto nitrocellulose 
membrane using the following method. Transfer cassettes contained the following layers: a 
sponge, Whatman 3MM blotting paper, nitrocellulose membrane (Pall corporation), SDS-
PAGE gel, Whatman blotting paper and a sponge (all equipment was pre-immersed in transfer 
buffer containing 20% v/v methanol, 0.19M glycine and 0.05M Tris). The transfer cassette 
was then placed in a transfer tank filled with transfer buffer for 6 hours at 280mA. Following 
the transfer, nitrocellulose membranes were stained to visualise proteins and subsequently 
destained in deionised water and TBST. Nitrocellulose membranes were kept in 5% skimmed 
dried milk (Marvel) in TBST for 30 minutes in order to block non-specific binding sites. 
Following blocking, primary antibodies (Table 2.4) were diluted in 5% skimmed dried milk in 
TBST and incubated with the nitrocellulose membrane overnight at 4°C on a rocking table. 
Following incubation with primary antibodies, nitrocellulose membranes were washed in 
TBST 6 times for 5 minutes each time. Nitrocellulose membranes were then incubated with 
secondary antibodies (Table 2.5) conjugated to horse-radish peroxidase (HRP) in 5% 
skimmed dried milk in TBST for 2 hours at room temperature. Following incubation, 
nitrocellulose membranes were again washed in TBST 6 times for 5 minutes each time. 
Proteins were then visualised by washing nitrocellulose membranes in enhanced chemi-
luminescence (ECL) reagent (Millipore or GE Healthcare) for 1 minute, sealed in saran wrap 
and exposed to autoradiography film (Kodak) for the required amount of time.  
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Table 2.5 Primary Antibodies used in this Study. Indicated are the primary antibodies used in 
this study, the antigens they target, molecular weight, dilution, use, species and source N.B. WB- 
Western Blot; IP- Immunoprecipitation; GST- GST pull-down.   
Antibody Antigen Dilution Use Species Company/Source 
2AG Ad5 E1B 1 in 20 WB, IP, GST Mouse Professor Arnold Levine 
β-Actin β-Actin 1 in 10000 WB Mouse Sigma 
BLM BLM 1 in 1000 WB, IP Rabbit Bethyl 
M73 Ad5 E1A 1 in 10 WB Mouse Harlow et al., 1985 
5DO2 Ad12 E1A 1 in 10 WB  Mouse In house 
Mre11 Mre11 1 in 1000 WB Mouse Genetex 
p53 p53 1 in 100 WB, IP Mouse Professor David Lane 
TOPBP1 TOPBP1 1 in 1000 WB Rabbit Dr Grant Stewart 
XPH9 Ad12 E1B 1 in 20 WB, IP, GST Mouse Merrick et al., 1991 
 
 
Table 2.6 Secondary Antibodies used in this Study. Indicated are the secondary antibodies used in 
this study, the antigen they target, dilution, use, species and source. 
Antibody Antigen Dilution Use Species Company/Source 
Mouse Mouse 1 in 2000 WB, IP, GST pull-down Goat Dako Laboratories 
Rabbit Rabbit 1 in 3000 WB, IP, GST pull-down Swine Dako Laboratories 
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2.4.2 Co-Imunnoprecipitation 
Cell lysate containing 5mg of protein as in Section 2.3.1 and was typically incubated with 
10μl of primary antibody (Table 2.3), rotating at 4°C overnight. Following overnight rotation, 
cell lysates were centrifuged at 45,000 rpm at 4°C for 10 minutes and the pellet discarded. 
40μl of Protein G-agarose beads (Sigma) were added to the cell lysates and rotated at 4°C for 
1 hour. The samples were then centrifuged at 3,000 rpm for 1 minute at 4°C and supernatant 
discarded. Samples were then washed four times in 1ml of NETN buffer, centrifuging at 
3,000 rpm at 4°C for 1 minute and discarding the supernatant each time. 50μl of Laemmli 
sample buffer was added to the samples, heated to 80°C for 5 minutes, centrifuged at 13,000 
rpm for 1 minute and resolved by SDS-PAGE.  
 
2.5 Molecular Biology Techniques 
2.5.1 GST-Fusion Protein Production 
10mls of Luria Bertani (LB)-broth (10g/L tryptone (Fisher Scientific), 10g/L NaCl and 5g/L 
yeast extract (Fisher Scientific)) supplemented with 100μg/ml ampicillin (Sigma) was 
inoculated with a colony of BL21 E. coli transformed with gene constructs (Table 2.7), and 
left in an orbital incubator at 37°C overnight. Following overnight incubation, 5mls of each 
LB-broth culture was added to 500mls of LB-broth supplemented with 100μg/ml of 
ampicillin, and grown at 220 rpm, 37°C until cultures reached an optical density of 0.6-0.7 
absorbency units. 0.5mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma) was then 
added to the cultures and grown for a further 3 hours at 30°C, 220 rpm. Following incubation, 
cultures were centrifuged at 6,000 rpm for 15 minutes, supernatants discarded and pellets 
frozen at -80°C until required.  
 
 26 
2.5.2 GST-Fusion Protein Purification 
Bacterial pellets were resuspended in 30mls of Buffer A (2mM EDTA, 1% Triton X100 
(Sigma) in PBS) and sonicated twice for thirty seconds each time and centrifuged at 18,000 
rpm for 5 minutes and pellet discarded. The bacterial cell lysate was centrifuged for a further 
18,000rpm for 30 minutes and the pellet discarded. 2mls of 50:50 PBS: glutathione-agarose 
beads were added to the supernatant and rotated for 3 hours at 4°C. Samples were centrifuged 
at 2,000 rpm for 5 minutes, and to the supernatant 1ml of 50:50 PBS: glutathione-agarose 
beads were added and rotated at 4°C for a further hour. Meanwhile, pelleted beads were 
washed in 30mls of Buffer A three times, centrifuging at 2,000 rpm for 5 minutes at 4°C each 
time. Samples were then washed in 30mls of Buffer B, and centrifuged at 2,000 rpm, 4°C for 
minutes. To the beads, 2mls of 25mM glutathione (pH 8.2) was added and rotated at 4°C for 1 
hour. Samples were then spun at 2,000 rpm for 5 minutes and supernatant retained. 
Glutathione was removed from the GST-fusion proteins by dialysis at 4°C overnight. 
Supernatants were transferred to dialysis tubing and dialysed overnight against in buffer 
containing 150mM NaCl, 25mM Tris (pH 7.5) and 1mM dithiothreitol (DTT) (Sigma).  
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Table 2.7 Gene Expression Constructs for GST-Fusion Protein Production. Indicated 
are the BLM gene fragments used in this study, the vectors they were ligated into and their 
source. BLM gene fragments were ligated into pGEX-4T-1 vectors (provided by Dr 
Sengupta) which contain an ITPG-inducible promoter, an ampicillin resistance gene and a 
GST gene. These gene expression constructs were used to produce the GST-BLM fusion 
proteins used in this study. 
Gene Vector  Source 
BLM WT Fragment (aa 1-1417) pGEX-4T-1 Dr Sengupta 
BLM Fragment 1 (aa 1-212) pGEX-4T-1 Dr Sengupta 
BLM Fragment 2 (aa 191-660) pGEX-4T-1 Dr Sengupta 
BLM Fragment 3 (aa 621-1041) pGEX-4T-1 Dr Sengupta 
BLM Fragment 4 (aa 1001-1417) pGEX-4T-1 Dr Sengupta 
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Results 
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3.1 BLM is Degraded Following Infection with Adenovirus Serotypes 4, 5 and 12 
In order to confirm preliminary evidence from our laboratory that certain adenovirus 
serotypes are able to degrade BLM, HeLa cells infected with Ad3, 4, 5, 7, 9, 11 and 12 
serotypes were harvested at 0, 24, 48, 72 and 96 hours post-infection and subjected to 
Western blotting (Figure 3.1). BLM was immuno-blotted, along with β-Actin as a loading 
control, and TOPBP1, Mre11 and p53 as controls which are known to be degraded during 
infection with various Ad serotypes. As expected, protein levels of TOPBP1 throughout the 
course of Ad3, 4, 5, 7, 9, 11 infection remained the same, whilst TOPBP1 was degraded 24 
hours post-Ad12 infection. Protein levels of Mre11 during Ad3, 7, 9 and 11 infections 
remained unchanged throughout the course of infection, whilst Mre11 was degraded 48 hours 
post-Ad4, 5 and 12 infection. p53 protein expression is induced in cells infected with 
Adenovirus serotypes 3, 7, 9 and 11, whilst p53 was degraded during Ad 4, 5 and 12 infection 
as anticipated (Blackford et al, 2010; Forrester et al., 2011). Early adenoviral proteins E1A 
and E1B were also immuno-blotted to confirm infection with Ad 5 and 12 serotypes. Due to 
lack of appropriate antibodies, infection with Ad3, 4, 7, 9 and 11 serotypes was confirmed by 
Ponceau-S staining of nitrocellulose membranes to visualise viral structural proteins (data not 
shown). Protein levels of BLM after infection with Ad3, 7, 9 and 11 serotypes remained 
constant throughout the duration of infection. Infection with Ad4, 5 and 12 serotypes resulted 
in the degradation of BLM; after 24 hours during Ad5 and 12 infection, and 48 hours post-
Ad4 infection (Figure 3.1).  
 
 
 
 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad3 infection 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad4 infection 
BLM 
TOPBP1 
Mre11 
E1A 
E1B 
p53 
β-Actin 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad5 infection 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad7 infection 
Figure 3.1: Degradation of BLM Following Adenovirus Infection. HeLa cells were 
infected with various adenovirus serotypes, harvested at 0, 24, 48, 72 and 96 hours post-
infection and subjected to Western Blotting for BLM. In addition, β-Actin was immuno-
blotted as a loading control, along with Mre11, p53 and TOPBP1 as controls which are 
known to be degraded during infection with certain adenovirus serotypes. These data are 
representative of one experiment performed three times independently. 
Hours post-
infection: 
Hours post-
infection: 
Hours post-
infection: 
Hours post-
infection: 
30 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
E1A 
E1B 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad12 infection 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad9 infection 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
0 
hr
 
24
 h
r 
48
 h
r 
72
 h
r 
96
 h
r 
Ad11 infection 
BLM 
TOPBP1 
Mre11 
p53 
β-Actin 
Hours post-
infection: 
Hours post-
infection: 
Hours post-
infection: 
Figure 3.1 Continued: Degradation of BLM Following Adenovirus Infection. HeLa cells 
were infected with various adenovirus serotypes, harvested at 0, 24, 48, 72 and 96 hours post-
infection and subjected to Western Blotting for BLM. In addition, β-Actin was immuno-
blotted as a loading control, along with Mre11, p53 and TOPBP1 as controls which are 
known to be degraded during infection with certain adenovirus serotypes. These data are 
representative of one experiment performed three times independently. 
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3.2 The Adenovirus E1B Protein is Required for the Degradation of BLM during 
Adenovirus Infection. 
In order to determine which adenoviral proteins are responsible for the degradation of BLM 
during adenovirus infection, HeLa cells infected with mutant Ad5dl1520 (Ad5 E1B- mutant), 
Ad12dl620 (Ad12 E1B- mutant), Ad5dl355 (Ad5 E4orf6- mutant) and h5pm4155 (Ad5 E4- 
mutant) viruses were harvested at 0, 24, 48, 72 and 96 hours post-infection and subjected to 
Western blotting for BLM (Figure 3.2). β-Actin was also immuno-blotted as a positive 
loading control, along with TOPBP1, Mre11, p53 as positive controls and Ad5 or 12 E1A and 
E1B-55K. In Ad5dl1520 and Ad12dl620 infected HeLa cells, levels of BLM remained 
constant throughout infection, suggesting that the degradation of BLM is E1B-dependent 
during both Ad5 and 12 infection. In Ad5dl355 and h5pm4155 infected HeLa cells, levels of 
BLM also remained constant throughout infection, suggesting that the degradation of BLM is 
E4-dependent during Ad5 infection (Figure 3.2). 
 
3.3 Adenovirus Early Region E1B-55K Interacts with BLM in Vivo 
In order to assess whether Ad E1B-55K interacts with BLM in vivo, co-immunoprecipitation 
assays were performed. Appropriate cell lysate was incubated with antibodies against BLM or 
E1B-55K and subsequent immuno-complexes were isolated from the cell lysates using 
Protein-G agarose beads and subjected to Western blotting for BLM or E1B-55K (Figure 3.3).  
Results from Figure 3.3A show that E1B-55K interacts with BLM in vivo in both 
Ad5E1HEK293 and Ad12E1HER2 cells. In a reciprocal experiment, immuno-precipitated 
BLM was immuno-blotted with antibodies against Ad5 and 12 E1B-55K proteins. Figure 
3.3B confirms that E1B-55K from both Ad5 and 12 serotypes infection interacts with BLM in 
vivo. 
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Figure 3.2: Degradation of BLM Following Mutant Adenovirus Infection. HeLa cells were 
infected with mutant adenoviruses, harvested at 0, 24, 48, 72 and 96 hours post-infection and 
subjected to Western blotting for BLM. β-Actin was also immuno-blotted as a loading control, 
along with p53, Mre11 and TOPBP1, also as controls, and E1A and E1B to assess for infection. 
These data are representative of one experiment performed twice. 
Hours post-
infection: 
Hours post-
infection: 
Hours post-
infection: 
Hours post-
infection: 
33 
Figure 3.3: BLM Interacts with E1B-55K in vivo in both Adenovirus 5 and 12 
Transformed Cell Lines. Appropriate cell lysate was incubated with antibodies against 
BLM or Ad5/Ad12 E1B-55K, protein-protein complexes were isolated using Protein-G 
beads and subjected to Western blotting for: A. E1B-55K or B. BLM. These data are 
representative of one experiment performed twice. 
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3.4 The Ad E1B-55K Protein Directly Interacts with BLM in Vitro 
In order to assess whether the E1B-55K protein directly interacts with BLM in vitro, and to 
see which region of BLM E1B-55K binds, GST pull-down assays were performed. In order to 
perform these GST pull downs, various GST-BLM fragments were constructed (Table 2.4) 
(Figure 3.4). Purified GST-fusion proteins (Table 2.7) were resolved by SDS-PAGE and 
SDS-PAGE gels were Coomassie Blue stained to assess the purity of the GST-fusion proteins 
produced (Figure 3.5). Following assessment of the purity of the GST-fusion proteins 
produced, Ad5E1HER911, Ad5E1HEK293, Ad12E1HER10 and Ad12E1HER2 cell lysates 
were incubated with GST-fusion proteins and resulting protein complexes were isolated using 
glutathione-agarose beads. Protein complexes were subjected to Western blotting for Ad5 or 
Ad12 E1B-55K, depending on the cell lysate used, along with GST protein alone and cell 
lysate alone as non-specific binding and positive controls, respectively. Using Ad12 
transformed cell lysates Ad12E1HER2 and Ad12E1HER10, protein complexes following 
GST pull-down were immuno-blotted for Ad12 E1B-55K, showing in both lysates, E1B-55K 
interacts with GST-BLM fragment 2 (191-660aa) in vitro (Figure 3.4 and 3.6).  Using Ad5 
transformed cell lysates Ad5E1HER293 and Ad5E1HEK911, protein complexes following 
GST pull-down were immuno-blotted for Ad5 E1B-55K, showing in both lysates, E1B-55K 
interacts with GST-BLM fragment 1 (aa 1-212) and fragment 2 (aa 191-660) in vitro (Figure 
3.4 and 3.6).     
 
3.5 Degradation of BLM during Adenovirus Serotype 5 and 12 Infection is Proteasome 
Dependent 
In order to assess whether the degradation of BLM during infection with Ad 5 and 12 was 
dependent on the proteasome, HeLa cells were infected with Ad5 or 12 and treated with the  
1-1417 
(WT) 
1 64
9 
10
77
 
12
12
 
12
92
 
14
17
 
10
06
 
Helicase RQC HRDC 
1-212 
(Fragment 1) 
191-660 
(Fragment 2) 
621-1041 
(Fragment 3) 
1001-1417 
(Fragment 4) 
Figure 3.4 Structure of BLM and Associated Domains. Schematic 
representation of BLM and the GST-BLM fragments used in this study. 
Amino acid numbers are indicated above the full length BLM schematic. 
Various domains are indicated. RQC, RecQ carboxy-terminal; HRDC, 
Helicase and Rnase D C-terminal (modified from Srivastava et al., 2009). 
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Figure 3.5: Assessment of the Protein Quality of the GST-BLM Fragments Produced 
in this Study. Plasmid DNA constructs were transformed into BL21 E.Coli in order to 
produce various GST-fusion proteins. GST-fusion proteins were purified, resolved by 
SDS-PAGE, Coomassie Blue stained and subsequently destained to assess protein purity.  
G
ST
-W
T 
 
G
ST
 fr
ag
m
en
t 1
 
G
ST
 fr
ag
m
en
t 2
 
G
ST
 fr
ag
m
en
t 3
 
G
ST
 fr
ag
m
en
t 4
 
M
ar
ke
r 
77KDa 
66KDa 
45KDa 
GST 
37 
G
ST
 
G
ST
-B
LM
 W
T 
G
ST
-B
LM
 fr
ag
m
en
t 1
 
G
ST
-B
LM
 fr
ag
m
en
t 2
 
G
ST
-B
LM
 fr
ag
m
en
t 3
 
G
ST
-B
LM
 fr
ag
m
en
t 4
 
Ly
sa
te
 
Ad12 E1B-55K 
Ad12 E1B-55K 
Ad12E1HER2 
Ad12 E1HER10 
Ad5 E1B-55K 
Ad5 E1B-55K 
Ad5E1HEK293 
Ad5E1HER911 
Figure  3.6: The E1B-55K Protein Directly Interacts with BLM in Vitro. 
Ad5E1HER911, Ad5E1HEK293, Ad12E1HER10  and Ad12E1HER2 cell lysates 
were incubated with various GST-BLM fusion proteins. Protein complexes were 
isolated with glutathione-agarose beads and subjected to Western blotting for Ad5 or 
12 E1B-55K, depending on the cell lysate used. These data are representative of one 
experiment performed twice independently. 
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pan-proteasome inhibitor MG132. Cells infected with Ad5 and MG132 treated were 
harvested, with infected, untreated controls in parallel, at 0, 24hr and 48hr post-infection, 
whilst cells infected with Ad12 and MG132 treated were harvested, with infected, untreated 
controls in parallel, at 0, 12 and 24hrs post-infection. Both were subjected to Western blotting 
for β-Actin (loading control), Mre11 (positive control) and BLM (Figure 3.7). BLM was 
partially degraded by 24 hours post-Ad5 infection in untreated HeLa cells, in cells treated 
with the proteasome inhibitor, BLM was degraded by 48 hours post-Ad5 infection. In 
untreated cells infected with Ad12, BLM was degraded 24 hours post-Ad12 infection, whilst 
in cells treated with MG132, BLM was only partially degraded 24 hours post-Ad12 infection. 
These data suggest that the degradation of BLM during Ad5 and 12 infection is, at least, 
partially dependent upon the proteasome (Figure 3.7). 
 
3.6 Cullin 4B is Partially Required for the Degradation of BLM during Adenovirus 
Infection 
Ad5 and Ad12 infected HeLa cell lysates which had been previously treated with siRNAs to 
silence expression of various Cullins including CUL2, CUL4A, CUL4B, CUL5 and CUL7 for 
Ad5 infection, and CUL2, CUL5 and CUL7 for Ad12 infection were harvested at 0, 24 and 
48 hours post-infected and subjected to Western blot analysis (Figure 3.8). In Ad5 infected 
HeLa cells, silencing of Cul2, Cul5, Cul4A and Cul7 resulted in the degradation of BLM 
similar to that of the non-silencing control, suggesting that these Cullins are not responsible 
for degradation of BLM. However, in Ad5 infected HeLa cells treated with Cul4B siRNA, 
BLM still appeared to be partially present 48 hours post-infection, suggesting that silencing of 
Cul4B expression partially stabilises BLM degradation. In Ad12 infected HeLa cells,  
0h
r 
24
hr
 
48
hr
 
48
hr
 
24
hr
 
0h
r 
+ MG132 - MG132 
Ad5 infection 
0h
r 
0h
r 
24
hr
 
24
hr
 
12
hr
 
12
hr
 
+ MG132 - MG132 
Ad12 infection 
Hours post-infection: 
BLM 
Mre11 
β-Actin 
Figure 3.7: Degradation of BLM During Adenovirus 5/12 Infection is Dependent on 
Proteasome Activity. HeLa cells were infected with Ad5 or 12, were treated with the 
proteasome inhibitor MG132 and harvested at 0, 24 and 48 hour time points for Ad5 
infected cells, and 0, 12 and 24 hour time points for Ad12 infected cells. Lysates were 
subjected to Western blotting for β-Actin as a loading control, Mre11 as a positive control 
and BLM. These data are representative of one experiment performed two times 
independently. 
40 
 41 
silencing of Cul2, Cul5 and Cul7 resulted in the degradation of BLM similar to that of the 
non-silencing control, suggesting that these Cullins are not responsible for the degradation of 
BLM. Unfortunately there was not sufficient Cul4B siRNA available to determine the effect 
during Ad 12 infection (Figure 3.8). 
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control, various Cullins to assess silencing efficiency, E1B-55K as an infection control and 
BLM. These data are representative of one experiment performed twice. 
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Figure 3.8 Continued: The Effect of Cullin knock-downs on BLM Degradation. HeLa cell 
lysate from cells infected with Ad12 and treated with siRNAs against various Cullins, were 
harvested after 0, 24 and 48 hours post-infection and subjected to Western blotting for β-Actin 
as a loading control, various Cullins to assess silencing efficiency, E1B-55K as an infection 
control and BLM. These data are representative of one experiment performed twice. 
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Chapter Four: 
 
Discussion 
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4. Discussion 
Our laboratory first suggested an association between BLM and adenovirus after mass 
spectrometric analysis of adenovirus E1B-55K binding partners showed that BLM associated 
with E1B-55K in vivo (Forrester, unpublished data 2010). Following this, our laboratory 
investigated this interaction further by looking at BLM protein levels during the course of 
adenovirus infection. Preliminary data suggested that BLM is degraded throughout infection 
with various adenovirus serotypes. To our knowledge there was no other evidence to suggest 
an association between adenovirus and BLM at the beginning of this study. However, during 
this project a paper was published suggesting that Ad5 is responsible for the degradation of 
BLM, mirroring the work that was on going in our laboratory (Orazio et al., 2011).  
 
The first objective of this study was to confirm the preliminary observations that certain 
adenovirus serotypes are able to degrade the RecQ helicase BLM (Objective 1, Section 1.9). 
The work presented in this study confirmed that BLM is degraded during Ad4, 5 and 12 
infection. During infection with Ad5 and Ad12, BLM was degraded by 24 hours post-
infection, and during Ad4 infection, BLM was degraded 48 hours post-infection (Figure 3.1). 
This confirms the preliminary evidence in our laboratory and in addition, confirms the 
findings from the recent study by Orazio et al. demonstrating that BLM is degraded during 
Ad5 infection (Orazio et al., 2011). In addition to confirming these findings, we have also 
identified two novel adenovirus serotypes, 4 and 12, which also degrade BLM during 
infection.   
 
To date, there has been no assigned role for the degradation of BLM during adenovirus 
infection. We suggest a number of reasons why adenoviruses could target BLM. It is already 
 46 
known that adenoviruses target components of the HRR pathway (e.g. MRN), in order to 
prevent DNA damage repair and in turn prevent processing and ligation of viral DNA ends 
(Carson et al., 2003; Stracker et al., 2002). Recent evidence suggests that BLM has important 
pro-recombinase roles in HRR both during DNA end resectioning and resolving of 
recombination intermediates (Section 1.7).  Evidence that BLM has important roles in DNA 
end resectioning comes from studies that have shown that BLM is able to associate with 
Exonuclease 1, and stimulate its nuclease activity to resect dsDNA to ssDNA (Nimonkar et al, 
2008; Gravel et al, 2008). In addition, BLM can also interact with Rad54 and stimulate its 
activity, also promoting HRR (Srivastava et al, 2009). These events occur early in the HRR 
pathway and may explain why BLM is degraded in the early stages of infection. Degradation 
of BLM and the subsequent inhibition of the HRR pathway may be advantageous during 
adenovirus infection as to inhibit the recombinase activity of BLM, so that BLM cannot 
interfere with adenovirus replication by resolving ends of viral genomes. There is 
considerable evidence to indicate that Ad5 targets multiple components of pathways they 
need to deregulate or disrupt (Section 1.4). BLM has also been shown to have roles in the 
later stages of the HRR pathway, converging double Holliday junctions through its interaction 
with Topoisomerase 3α (Wu et al, 2006; Raynard et al, 2006). The implications of this 
function of BLM in the context of adenovirus infection are unclear at present. On the other 
hand, some evidence suggests that BLM has anti-recombinase activities, therefore inhibiting 
HRR.  Indeed, Bloom’s syndrome patients with mutated BLM have excessive HRR and 
subsequent genomic instability, suggesting that BLM predominantly acts as an anti-
recombinase. In addition, BLM is able to interact with Rad51, inhibiting polymerisation and 
nucleofilament formation, and therefore inhibiting HRR (Bugreev et al., 2007). Intriguingly, 
other adenovirus serotypes which do not degrade BLM replicate normally (adenovirus 
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serotypes 3, 7, 9 and 11), suggesting that the degradation of BLM is not essential for viral 
replication. However these viruses also fail to degrade p53, Mre11 and TOPBP1 and so they 
obviously employ other strategies for inhibiting DNA break repair, possibly through the 
degradation of DNA ligase IV (Baker et al., 2007). These intriguing inconsistencies will 
hopefully be resolved by future investigation. 
 
The next objective of this study was to determine which viral proteins are responsible for the 
degradation of BLM during adenovirus infection (Objective 2, Section 1.9). Using mutant 
viruses, data obtained in this study demonstrated that E1B-55K and E4orf6 are essential for 
BLM degradation during Ad5 infection, confirming the result also obtained by Orazio et al 
(Figure 3.2) (Orazio et al., 2011). In addition to these findings, we were also able to show that 
the degradation of BLM during Ad12 infection is dependent on E1B-55K, but unfortunately 
no Ad12 virus mutant in E4 was available to determine if BLM degradation is E4 dependent, 
although this seems highly likely (Figure 3.2). In addition, no mutant Ad4 viruses were 
available to investigate whether BLM degradation was also E1B-55K and E4 dependent. 
However, overall these findings suggest that the E1B55K/E4orf6 linked E3 ubiquitin ligase 
complex is responsible for the degradation of BLM during Ad5 and 12 infection. 
 
A further objective of this study was to validate a role for the E1B-55K protein during the 
degradation of BLM (Objective 3a, Section 1.9). Co-immunoprecipitation assays showed that 
E1B-55K interacts with BLM during infection with both Ad5 and 12 (Figure 3.3). 
Unfortunately no Ad4 E1B-55K antibody was available to assess BLM interactions during 
Ad4 infection. These results further validate a role for E1B-55K in the degradation of BLM, 
probably acting as a link between the substrate and E4orf6 and the E3 ligase. 
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Following confirmation of E1B-55K interactions with BLM in vivo, the next objective of this 
study was to determine with which region of BLM E1B-55K interacts (Objective 3b, Section 
1.9). Our results showed that Ad5 E1B-55K associates with GST-BLM fragment 1 
(incorporating amino acids 1-212) and GST-BLM fragment 2 (incorporating amino acids 191-
660) (containing part of the helicase domain) in vitro. Interestingly, Ad12 E1B-55K 
associates with GST-BLM fragment 2 only, suggesting that different Adenovirus serotypes 
may have evolved different binding sites (Figure 3.6). Although the binding site for Ad5E1B-
55K on p53 has been determined (Lin et al., 1994), no site of interaction for any other 
proteins degraded during Ad5 infection has been mapped. Comparison of the amino acid 
sequences of BLM and the proposed E1B-55K binding site on p53 shows a region of 
homology around amino acids 425-430. Tryptophan 23 and proline 27 in p53 have been 
suggested to be of particular importance for interaction with Ad5E1B55K and these are 
conserved in BLM. Significantly, this suggested binding site is present in GST-BLM 
fragment 2 which interacts with Ad5 and Ad12 E1B-55K proteins (Figure 4.1). Interestingly, 
a comparible site is present in Mre11 although the homology is not so marked (Hartl et al., 
2008). 
                     
The next objective of this study was to further elucidate a role for the interaction between 
E1B-55K and BLM (Objective 4a, Section 1.9). As previously discussed, using mutant 
viruses we were able to show that BLM degradation is dependent on E1B-55K and E4orf6 
during Ad5 infection, and although Ad12 E4 and Ad4 mutant viruses were unavailable, this 
does suggest that the E1B-55K/E4orf6 ligase complex may be responsible for the of BLM. 
Our results showed that degradation of BLM during Ad5 and 12 infection were dependent on 
Identical 
Similar 
Figure 4.1: Comparison of the Amino Acid Sequences of BLM and p53 
in the Proposed Binding Site for Ad5E1B-55K. Comparison of 
Ad5E1B-55K?s binding site to p53 and BLM?s amino acid sequence 
reveals a region of homology between amino acids 425 and 43. 
Significantly, this region of homology is present within the GST-BLM 
fragment 2 which has been shown to interact with both Ad5 and Ad12 
E1B-55K proteins in this study (Lin et al., 1994). 
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the proteasome, suggesting that E1B-55K/E4orf6 complex targets BLM for proteasomal 
degradation (Figure 3.7). 
 
The study from Orazio et al suggested that Cul5 is a component of the E1B-55k/E4orf6 E3 
ubiquitin ligase complex which is responsible for the degradation of BLM during Ad5 
infection. In order to show this, a Cul5 dominant negative gene, comprising the N-terminal 
domain of Cul5, which is unable to ubiquitinate substrates, was transfected into cells. It was 
found that BLM was no longer degraded in these cells, suggesting that Cul5 is essential for 
the degradation of BLM (Orazio et al, 2011). However, it has been suggested that the use of 
this dominant negative Cul5 construct also inactivates other Cul E3 ubiquitin ligases, and so 
the inhibition of BLM degradation may not be due to inactivation of Cul5, but due to 
inactivation of all of the Cullins. In order to investigate this more fully, we reduced the 
expression of various Cul’s using siRNA to examine the effect on BLM degradation 
(Objective 4b, Section 1.9). Silencing of Cul5 did not affect BLM degradation during Ad5 
infection, and in addition did not affect BLM degradation during Ad12 infection (Figure 3.7). 
In addition, silencing of Cul2, 4A and 7 in Ad5 infection did not affect BLM degradation. 
Interestingly, reduction of Cul4B expression seemed to partially stabilise BLM degradation 
during Ad5 infection, suggesting that Cul4B may be involved in the E1B-55K/E4orf6 
complex that is involved in BLM degradation. Silencing of Cul2 and Cul7 during Ad12 
infection did not affect BLM degradation. Unfortunately, sufficient Cul4A and Cul4B siRNA 
was not available to determine their possible role during Ad12 infection.     
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4.1 Limitations 
 
One issue during this study was the lack of mutant viruses available to determine which viral 
proteins were responsible for the degradation of BLM. We were able to confirm that the 
degradation of BLM during Ad5 infection was dependent on both E1B and E4, probably 
working together as an E3 ligase to degrade BLM (Figure 3.2). In addition, we were able to 
determine that degradation of BLM during Ad12 infection was dependent on E1B activity. 
However, no mutant Ad12 E4 virus was available to determine if degradation of BLM is 
additionally dependent on E4 activity during Ad12 infection. In addition, no mutant Ad4 
viruses were available to determine if the degradation of BLM was dependent on E1B/E4 
activity. Access to such mutant viruses would have provided us with a complete set of data, 
helping us to further elucidate the interaction between BLM and adenovirus. We were unable 
to obtain to any Ad4 serotype antibodies throughout the duration of this study, meaning we 
were unable to confirm the potential interaction between BLM and E1B-55K both in vitro and 
in vivo during Ad4 infection (Figure 3.3 and 3.5). Due to limited availability of siRNAs, 
unfortunately we were unable to knock-down gene expression of Cul4A and 4B during Ad12 
infection. Therefore, we were unable to determine whether knock-down of Cul4A partially 
stabilised BLM degradation, as in Ad5 infection (Figure 3.7). In addition, we were unable to 
knock-down gene expression of any Cullins during Ad4 infection, due to the lack of siRNA 
available in our laboratory. 
 
4.2 Future Work 
In order to circumvent the limitations in this study, it would be beneficial to obtain mutant 
Ad12 E4 virus, and also a mutant Ad4 E1B-55K and E4 virus. This would allow us to 
determine whether different adenovirus serotypes adopt the same mechanism of BLM 
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degradation as in Ad5 infection. It would also be beneficial to assess the effect of BLM 
degradation after knock-down of Cul4A and 4B gene expression during Ad12 infection, to 
determine whether the degradation of BLM is partially stabilised after knock-down of Cul4B 
gene expression, as in Ad5 infection (Figure 3.7). Access to additional Cul2, 4A, 4B, 5 and 7 
siRNAs would also be useful to assess whether knock-down of Cul4B gene expression also 
stabilises BLM degradation during Ad4 infection.  
 
In addition to circumventing the limitations associated with this study, a number of other 
experiments would further elucidate the relationship between the adenoviruses and BLM. 
Immunofluorescence microscopy could be undertaken to observe the localisation of BLM 
during adenovirus infection. It would be interesting to determine if BLM localises to viral 
replication centres during adenovirus infection. In addition, it may be interesting to repeat 
these immunofluorescence assays using mutant viruses which do not degrade BLM (Figure 
3.2), to compare differences in BLM localisation. 
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Abstract 
Kaposi’s sarcoma associated herpesvirus (KSHV) is a double-stranded DNA virus belonging 
to the herpesvirus subfamily. Complex cellular defence mechanisms limit the potential for 
viruses, including KSHV, to replicate in the host. Such defences include the interferon 
response that can restrict virus replication and contain spread.  It is becoming increasingly 
apparent that in addition to these immune defences, the cellular response to DNA damage also 
functions as an important anti-viral mechanism. Here we present the first report showing that 
de novo KSHV infection can activate components of the cellular DNA damage response; 
namely phosphorylation of ataxia-telangiectasia mutated (ATM), NBS1, Chk1, replication 
protein A (RPA) and H2AX. In addition, we show that KSHV reactivation to evoke lytic 
replication also activates components of the DNA damage response; namely phosphorylation 
of ATM, Chk2, RPA and H2AX. The inhibition of the ATM/ataxia-telangiectasia mutated 
and RAD3-related (ATR) signalling pathways may be important for KSHV infection 
efficiency, since abrogation of these signalling pathways improves KSHV infectivity. 
Curiously, abrogation of the ATM/ATR signalling pathways during KSHV reactivation 
impeded reactivation, suggesting a complex relationship between KSHV and the cellular 
DNA damage response. Finally, we have shown that KSHV is able to both inhibit, and induce 
the cellular DNA damage response, depending on the context, in response to DNA damaging 
agents, bringing another level of complexity to the relationship. Taken together, these data 
reveal a complex interaction between KSHV and the DNA damage response that requires 
further study to delineate the mechanism and understand the consequences for pathogenesis. 
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1. Introduction 
1.1 Kaposi’s Sarcoma-Associated Herpesvirus 
Kaposi’s sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8 (HHV-8), is a 
large double-stranded DNA rhadinovirus belonging to the gamma-herpesvirus subfamily 
(Mesri et al., 2010). Similarly to other herpesviruses, individuals infected with KSHV are life-
long carriers, a result of KSHV’s ability to successfully evade the host immune response 
(Coscoy, 2007). Thus, KSHV exists in one of two replicative phases, the first, known as 
latency, is a programme whereby viral gene expression is limited to a small number of genes 
and the production of infectious virions is prohibited. It is in this latent phase that the virus is 
effectively invisible to the host immune system. In response to certain stimuli, KSHV can 
become ‘reactivated’, or lytic, whereby a range of KSHV genes associated with viral 
replication are expressed, enabling the production of infectious virus particles. This process of 
reactivation is executed by the expression of the viral lytic switch gene, replication 
transactivation activator (RTA) (Miller et al., 1997). Like other members of the herpesvirus 
subfamily, the KSHV genome exists independently of the host genome in the infected cell in 
an episomal form (reviewed in Mesri et al., 2010). Originally identified in Kaposi’s sarcoma 
(KS) lesions in 1994, KSHV is recognised as the aetiological agent of both KS and primary 
effusion lymphoma (PEL) (Cesarman et al., 1996; Chang et al., 2004; Bouvard et al., 2009). 
In addition, KSHV infection is also associated with the development of Multicentric 
Castleman’s disease (Soulier et al., 1995). 
 
1.2 Contribution of KSHV Proteins to Oncogenesis 
A body of evidence suggests that expression of both latent and lytic KSHV proteins 
contributes to the oncogenic transformation of Kaposi’s sarcoma cells during KSHV 
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infection. Latency-associated nuclear antigen (LANA), vCyclin, vFLIP, viral micro-RNAs 
and Kaposins A and B are expressed during the latent phase of KSHV infection, the 
expression of these genes is thought to contribute to the malignant phenotype of KS (Mesri et 
al., 2010) (Figure 1.1). Besides its role of maintaining the KSHV viral episome, LANA has a 
number of functions which are thought to contribute to the oncogenicity of KSHV, including 
the inhibition of p53, pRB-E2F and Wnt signalling pathways, subsequently interfering with 
apoptotic, transcriptional and proliferative programmes, respectively (Radkov et al., 2000; 
Fujimuro et al., 2003; Shin et al., 2005). In addition, LANA has been shown to target the anti-
angiogenic protein VHL for proteasomal degradation and stimulate the expression of 
telomerase reverse transcriptase (TERT) (Verma et al., 2004; Cai et al., 2006). The expression 
of the KSHV latent viral protein vCyclin is thought to promote cell proliferation and, 
consequently, viral replication through its ability to activate cyclin-dependent kinase 6 
(CDK6) (Godden-Kent et al., 1997). Expression of the latent viral protein vFLIP contributes 
to oncogenesis through interaction with, and activation of, nuclear factor-kappaB (NF-κB) 
(Liu et al., 2002). Activation of NF-κB leads to a number of downstream effects including the 
activation of cytokines and chemokines, whilst additionally having important roles in the 
control of apoptosis, such as the activation of the anti-apoptotic proteins B-cell lymphoma 2 
(Bcl-2) and B-cell lymphoma extra large (Bcl-XL) (Guasparri et al., 2004; Sakakibara et al., 
2009). Expression of the latent viral protein Kaposin A has been shown to have transforming 
capabilities in rodent cell lines, whilst the expression of Kaposin B indirectly increases levels 
of pro-inflammatory cytokines through its ability to activate MK2, a MAPK-associated 
protein which inhibits the degradation of mRNA which is rich in AU regions and to which a 
number of cytokines belong (Muralidhar et al., 1998; McCormick and Ganem., 2005). 
 
Figure 1.1: The KSHV Episome. Schematic showing the 140kb KSHV genome. The 
KSHV genome contains 87 open reading frames (ORFs) and approximately 17 
microRNAs. Identified ORFs and the proteins they encode are indicated on the schematic, 
cellular orthologues are indicated in yellow, microRNAs are indicated in purple and 
latency-associated ORFs are indicated in green (reproduced from Mesri et al., 2010) 
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During lytic infection, a number of viral proteins are expressed which are thought to 
contribute to the oncogenicity of KSHV. These include vG-protein coupled receptor 
(vGPCR), vinterleukin-6 (vIL-6), vCC chemokine ligand (vCCL), vBcl-2, vinterferon 
regulatory factor (vIRFs) and K1 (Figure 1.1). vGPCR is able to induce a number of 
signalling cascades including the MAP kinase signalling pathway and the AKT/mTOR 
pathway. This results in the activation of multiple transcription factors including hypoxia-
inducible factor-1α (HIF1α), NF-kB amongst others which in turn are able to induce the 
expression of pro-inflammatory cytokines and chemokines, and pro-angiogenic factors 
(reviewed in Jham and Montaner., 2010). The expression of the viral orthologs vIL-6 and 
vCCL promote angiogenesis in experimental systems, their expression is also thought to 
promote cell proliferation and survival (Boshoff et al., 1997; Aoki et al., 1999; Stine et al., 
2000). Expression of vBCL-2 during KSHV infection leads to the inhibition of pro-apoptotic 
proteins and subsequently results in the inhibition of apoptosis. vIRF1 is able to inhibit 
apoptosis by inhibiting activation of p53 by ATM in response to DNA damage (Shin et al., 
2005). Expression of the lytic viral K1 protein contributes to transformation through its ability 
to activate the Akt anti-apoptotic pathway and inhibit the Fas-mediated apoptotic pathway 
(Tomlinson and Damania., 2004; Berkova et al., 2009). 
 
1.3 The DNA Damage Response 
During the early stages of tumourigenesis, DNA damage pathways are frequently inactivated, 
circumventing apoptosis and inhibiting cellular proliferation. It is becoming increasingly 
apparent that, in order for viruses to effectively replicate their genomes, they must inactivate 
components of the DNA damage response pathway, probably contributing to oncogenic 
transformation by these viruses (Lilley et al., 2007). The two primary ‘sensors’ of the DNA 
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damage response are the ataxia-telangiectasia mutated (ATM) and ataxia telangiectasia and 
Rad3-related (ATR) kinases. ATM responds to double-stranded DNA breaks often occuring 
as a result of ionising radiation (IR) exposure and cellular stress, whilst ATR primarily 
responds to single-stranded lesions and collapsed replication forks (Khanna and Jackson., 
2001). 
 
In single-stranded lesions, ssDNA is bound by replication protein A (RPA) and this complex 
recruits ATR via ATR-interacting protein (ATRIP), to the site of damage (Zou and Elledge., 
2003). The ssDNA-RPA complex recruits and subsequently activates the Rad17-replication 
factor C 2 (RFC2) clamp loader complex which causes the Rad9-Rad1-Hus1 complex to bind 
DNA (Yang and Zou., 2006). Topoisomerase II binding protein 1 (TOPBP1) then binds to 
ATRIP and the Rad9 component of the Rad9-Rad1-Hus1 complex which results in the 
activation of ATR (Kumagai et al., 2006). ATR is then able to phosphorylate a number of 
proteins involved in cell-cycle arrest and DNA repair including BRCA1, H2AX, BLM, Chk1 
and p53 (Figure 1.2) (Zhou and Bartek., 2004). 
 
Double-strand breaks are sensed by the Mre11-Rad50-Nbs1 (MRN) complex, which is able to 
activate ATM (Lee and Paul, 2005). ATM then phosphorylates H2AX, which recruits 
mediator of DNA damage checkpoint 1 (MDC1) to the site of DNA damage, resulting in the 
amplification of H2AX phosphorylation (Rogakou et al., 1998). Together, MDC1 and H2AX 
are able to recruit various DNA damage proteins to the site of the double-strand break 
including Chk2, BRCA1 and p53, which are subsequently phosphorylated by ATM, leading 
to cell-cycle arrest and DNA repair or, if the level of damage is too great, apoptosis (Figure 
1.2) (Stucki and Jackson., 2006; reviewed in Cimprich and Cortez, 2008). 
ssDNA 
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Figure 1.2: The DNA Damage Response Signalling Pathways. In response to single-strand 
breaks induced by IR (or collapsed replication forks), ssDNA is bound by RPA, which 
ultimately results in the association of ATRIP with ATR, leading to its activation. The activated 
ATR kinase is then able to phosphorylate and subsequently activate the DNA damage proteins 
indicated. The MRN complex is able to sense double-strand breaks induced by ionising 
radiation (or cellular stress). The MRN complex is then able to activate ATM, leading to the 
phosphorylation and subsequent activation of proteins involved in cell-cycle arrest, DNA 
repair and apoptosis. IR, ionising radiation; UV, ultra-violet radiation; DSBs, double-strand 
breaks; ssDNA, single-stranded DNA (Zhou and Bartek, 2004). 
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1.4 KSHV and the DNA Damage Response 
Complex defence mechanisms limit the potential for oncogenic viruses to replicate effectively 
in the host; such mechanisms include the host interferon response and activation of host-cell 
apoptotic pathways (Weitzman et al., 2010). It is becoming increasingly apparent that, in 
addition to evading these defences, many viruses exploit, circumvent or ‘hijack’ components 
of the DNA damage repair pathway in order to effectively replicate their genomes. In the 
context of KSHV infection, little is understood regarding KSHV’s involvement with the DNA 
damage response. A recent study from Shin et al demonstrated that carboxyl-terminal 
transactivation domain of KSHV vIRF is able to bind to, and inhibit, ATM activation. This 
study also showed that vIRF1 can inhibit the transcriptional activation activity of p53 by 
targeting p53 for proteasomal degradation. Taken together, vIRF1 is shown to inhibit the 
ATM/p53 signalling pathway, in order to avoid activation of the DNA damage pathway and 
subsequently promote viral replication (Shin et al., 2006). In another study, the immortalised 
endothelial cell line hTERT-HDMEC was transduced with a vCyclin retrovirus and the effect 
on the DNA damage proteins ATM, H2AX and Chk2 was examined. Interestingly, expression 
of vCyclin activated ATM, H2AX and Chk2, providing the first evidence to suggest that a 
KSHV viral protein is able to activate components of the DNA damage signalling pathway 
(Koopal et al., 2007).  
 
1.5 Other Herpesviruses and the DNA Damage Response 
γ-herpesvirus68 (MHV68) is a murine herpesvirus which is related to KSHV, encoding a 
number of conserved proteins such as vBcl-2, vCyclin, LANA and vGPCR (Figure 1.3) 
(reviewed in Barton et al., 2011). Interestingly, a number of studies demonstrate the 
involvement of the DNA damage response during MHV68 infection. MHV68 is able to 
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activate phosphorylation of H2AX via the expression of the viral protein, orf36, thereby 
activating the DNA damage response. Phosphorylation of H2AX appears to promote viral 
replication, since infection with mutant orf36 attenuated virus replication (mutated by 
transposon insertion in the kinase domain) (Tarakanova et al., 2007). These data are 
consistent with other reports that suggest the induction of the DNA damage response by 
MHV68 infection is important for effective viral replication. For example, treatment with the 
DNA damaging drug etoposide was shown to enhance MHV68 replication in B-cell lines 
(Forrest and Speck, 2008). Other members of the herpesvirus subfamily have also been 
associated with the cellular DNA damage response including herpes simplex virus 1 (HSV1), 
cytomegalovirus (CMV) and Epstein-Barr virus (EBV). HSV1 is able to activate the cellular 
DNA damage response; inducing the phosphorylation of RPA, NBS1, Chk2 and p53 
(Wilkinson and Weller, 2004; Shirata et al., 2005). In addition, HSV1 proteins have been 
associated with the redistribution of DNA damage proteins including ATRIP away from viral 
replication centres. Conflicting with previous data suggesting RPA is activated in response to 
HSV1 infection, some data suggests that RPA is also redistributed away from viral replication 
centres (Wilkinson and Weller, 2006). CMV infection also activates the cellular DNA damage 
response; ATM, Chk2, p53 and H2AX become phosphorylated during CMV infection. In 
addition, during CMV infection some DNA damage proteins, including ATM, Chk2 and a 
number of proteins involved double-strand break repair are mislocalised away from viral 
replication centres (Gaspar and Shenk, 2005; Luo et al., 2007). Activation of DNA damage 
proteins has also been observed during EBV infection. One study demonstrated that EBV 
lytic replication activates components of the DNA damage pathway, namely ATM, Chk2, 
H2AX and p53 (Kudoh et al., 2005). Another recent publication demonstrated that, during 
initial infection of primary B-cells with EBV, H2AX and ATM become phosphorylated,  
Figure 1.3: Conserved Proteins in both MHV68 and KSHV; an Indication that 
KSHV may be Involved with the DNA Damage Response. Schematic showing 
the genomes of KSHV and the closely related murine herpesvirus, MHV68. Note 
the conserved proteins, LANA, vCyclin, vGPCR and vBcl2, between the two 
viruses (modified from Barton et al., 2011). 
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whilst 53BP1 located to sites of DNA damage (Nikitin et al., 2010). The implications of these 
studies are discussed in Chapter 4.  
 
1.6 Aims 
It has become apparent that a number of herpesviruses, including KSHV, are able to interact 
with components of the cellular DNA damage response. At least in the context of KSHV, the 
details and consequences of these interactions are incompletely understood. Therefore, the 
principle aim of this study is to elucidate the relationship between KSHV infection and the 
cellular DNA damage response. In order to investigate this aim, the following objectives will 
be addressed: 
 
1. Determine the effects of de novo KSHV infection on components of the cellular DNA 
damage response 
2. Determine the effects of reactivation of KSHV lytic replication on components of the 
cellular DNA damage response 
3. Determine whether KSHV uses the cellular DNA damage response during infection 
by examining the effect of abrogation of ATM/ATR DNA damage signalling 
pathways during 
a) De novo KSHV infection 
b) Reactivation of KSHV lytic replication 
4. Determine the capacity of KSHV to modulate the DNA damage response to    
mutagenic treatments. 
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Chapter Two: 
 
 
Materials and Methods 
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2. Materials and Methods 
2.1 Tissue Culture Techniques 
2.1.1 Maintenance of Cell Lines 
Ad5E1HEK293 cells (Table 2.1) were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) (Sigma) supplemented with 10% foetal calf serum (FCS) (PAA Laboratories), 1.1% 
Penicillin-Streptomycin (Invitrogen) and 1.1% non-essential amino acids (NEAA) 
(Invitrogen). Both uninfected and infected Vero cells (Table 2.1) were maintained in MEM 
AQ medium (Sigma) containing 11.1% FCS, 1.1% NEAA, 0.002% Penicillin-Streptomycin 
and 5ug/ul puromycin (Sigma) (medium supplemented with puromycin for use with latently 
infected KSHV cells only). All cells lines were kept in a humidified 5% CO2, 37°C incubator. 
 
 
 
Table 2.1 Cell lines used in this study. The mammalian cell lines used throughout the duration of 
this project are indicated, as well as ATCC number and any additional information. 
Cell Line ATCC number Information 
Vero CCL-81 Cell line from the kidney epithelial cells of the African 
    green monkey 
VK219 N/A Vero cell line from the kidney epithelial cells of the African  
    green monkey latently infected with a recombinant KSHV 
    Virus (vKSHV.219) (Vieira and O’Hearn, 2004) 
Ad5E1HEK293 CRL-1573 Human adenovirus serotype 5 transformed human embryo 
    kidney cell line 
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2.1.2 Cell Culture 
To passage cells, adherent cells were washed twice in 0.15M saline (Sigma) (pre-warmed to 
37°C), subcultured using 5mls of 0.05% trypsin- ethylenediaminetetraacetic acid (EDTA) 
(Invitrogen) and stored in a 37°C incubator until all cells had lifted off of the dish/flask. 
Trypsin was then quenched by the addition of appropriate cell medium, which was then 
pooled into universal tubes and the cells pelleted by centrifugation at 1,200 revolutions per 
minute (rpm) for 5 minutes at room temperature. Cells were then resuspended in appropriate 
cell media to wash, and spun again at 1,200 rpm, for 5 minutes at room temperature. Pelleted 
cells were then resuspended in the appropriate cell medium and replated onto dishes/flasks at 
the required density.  
 
2.1.3 Reactivation of VK219 Cell Line to Induce Lytic Replication / Expansion of VK219 
Cells for KSHV Production 
Prior to reactivation the following day, VK219 cells (Table 2.1) (a gift from J.Vieira) which 
constitutively expresses green fluorescence protein (GFP) under the control of elongation 
factor-1a (EF-1a) promoter and red fluorescence protein (RFP) under the control of a lytic 
PAN promoter (Vieira and O’Hearn, 2004), were plated at a density of 3 x 106 cells/flask in 
10 T175 flasks in MEM AQ media (supplemented with 5µg/ml of puromycin) and incubated 
overnight.  Cells were washed in 0.15M saline and stimulated with 2.27mls of reactivation 
mix containing 12.4mls of recombinant Baculovirus (Back50) (also a gift from J. Vieira), 
12.4mls of MEM AQ medium supplemented with 10% FCS, 5.5% NEAA, 0.002% Penicillin-
Streptomycin (no puromycin) and 309ul of 1M sodium butyrate (Sigma), in order to promote 
KSHV lytic replication.  Cells were incubated at 37°C for 48 hours before harvesting KSHV, 
or alternatively as required.  
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2.1.4 Harvesting the Recombinant KSHV from VK219 cells 
Following 48 hour incubation, supernatants were collected from the T175 flasks and 
centrifuged at 2,000 rpm, 4°C for 15 minutes. The supernatant was decanted into Beckman 
tubes and spun at 13,500 rpm at 4°C for 4 hours. Supernatant was then discarded, 50µl of 
EBM-2 medium (no supplements) (Clonetics) was added to the pellets, tubes were sealed with 
nescofilm and left at 4°C overnight. The next day, medium containing the virus was pooled 
into a 1.5ml microfuge tube and centrifuged at 4,000 rpm for 4 minutes at room temperature. 
Supernatant was transferred to a new microfuge tube and stored at 4°C until required.  
 
2.1.5 Determination of KSHV Titre 
The day before titration, Ad5E1HEK293 cells were seeded onto a 96-well plate at a density of 
2 x 10
4
 cells per well in Ad5E1HEK293 medium. Prior to infection, serial dilutions of 
recombinant KSHV were prepared, diluted in EBM-2 medium (no supplements) at 1/100, 
1/500, 1/1000, 1/5000, 1/10000, 1/20000, 1/40000, 1/80000.  Ad5E1HEK293 cells were 
infected with each dilution of virus in duplicate and spun at 1,200 rpm for 30 minutes. 
Following the spin, cells were incubated at 37°C for 90 minutes. After 90 minutes, inoculums 
were removed, cells were washed once in Ad5E1HEK293 medium and incubated at 37°C for 
48hrs in Ad5E1HEK293 medium. After 48 hours, infected cells were counted, in duplicate, at 
a range of dilutions by visualisation of GFP expression by fluorescence microscopy. 
Following the cell counts, average infectious units (IU) per ml were calculated using the 
following formula: 
 
Virus titre (IU/ml): average number of GFP-positive cells x dilution factor x 10 
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2.1.6 KSHV Viral Infections 
The day before infection, Ad5E1HEK293 cells were seeded into 6-well plates at a density of 
6 x 10
5
 cells per well. On the day of infection, culture medium was removed and the cells 
were washed in 0.15M saline. Cells were infected with recombinant KSHV (vKSHV.219) 
virus at an multiplicity of infection (MOI) of 1, diluted in EBM-2 media (no supplements). 
Following addition of inoculums to the cells, cells were centrifuged at 1,200 rpm for 30 
minutes at room temperature. Following the spin, cells were incubated for 90 minutes at 
37°C. Inoculums were then removed and replaced with culture medium, and cells were 
incubated at 37°C until required. 
 
2.2 Cell Biology Techniques  
2.2.1 Exposure of Adherent Cell Lines to ultra-violet (UV) radiation 
Adherent cell lines were removed of cell medium which was left to incubate at 37°C whilst 
the cells were being treated. Cells grown in 6cm dishes were exposed to 20JM
-2
 of UV 
radiation to induce single-strand DNA breaks (lids of the tissue culture dishes were removed 
before exposure), medium heated to 37°C was returned and cells were left to incubate at 37°C 
in a humidified incubator until required.  
 
2.2.2 Exposure of Adherent Cell Lines to Ionising Radiation (IR) 
In order to induce double-stranded DNA breaks, adherent cell lines were exposed to 5 Grays 
of IR using a CS-137 irradiator (model CIS IBL 437). Following IR, cells were incubated at 
37°C in a humidified incubator until required.  
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2.2.3 Exposure of Adherent Cell Lines to Caffeine  
In order to inhibit the ATM/ATR kinases, 5mM of caffeine (Cal Biochem) was added to cell 
medium in sterile conditions and exposed cells were left to incubate at 37°C in a humidified 
incubator until required.   
 
2.2.4 Flow Cytometry 
Ad5E1HEK293 cells infected with vKSHV.219 were assessed for infectivity levels by 
measuring the percentage GFP expression using flow cytometry. Adherent Ad5E1HEK293 
cells were treated with 0.05% trypsin-EDTA for 3 minutes in a 37°C incubator or 
alternatively until all cells had come off the plate. Trypsin was then quenched by adding 
Ad5E1HEK293 medium to the cells. Cells were then centrifuged at 1,200 rpm for 5 minutes 
at room temperature. Following the spin, cells were resuspended in phospho-buffered saline 
(PBS) (Oxoid) and centrifuged once more. Following centrifugation, cells were fixed in 1% 
paraformaldehyde (PFA) (Fisher Scientific) in PBS, and GFP expression was quantified using 
a Coulter XL-MCL flow cytometer (Beckman-Coulter).  
 
2.2.5 Fluorescence Microscopy 
Visualisation of GFP and red RFP expression of VK219 and Ad5E1HEK293 infected cells 
was achieved using a Nikon eclipse E600 microscope and images processed using image-pro 
express software. 
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2.3 Protein Chemistry Techniques 
2.3.1 Harvesting Adherent Cells from Culture Dishes 
Adherent cells grown on tissue culture flasks/dishes were harvested by one of two methods. 
Firstly, adherent cells were washed twice in 0.15M ice-cold saline, in the second wash, cells 
were removed from the tissue culture flask/dish with a cell scraper and pelleted at 1,200 rpm, 
4ºC for 5 minutes. Cells were resuspended in ice-cold 0.15M saline, pelleted again, any 
residual saline was removed and cells were resuspended in 400µl of Urea-Tris-β-
mercaptoethanol (UTB) lysis buffer containing 9M urea (Sigma), 150mM β-mercaptoethanol 
(Sigma) and 50mM Tris (Melford)/HCl pH 7.5 (Fisher Scientific), and pooled into 1.5ml 
microfuge tubes. Cell lysates were then sonicated twice for 10 seconds each time, centrifuged 
at 13,000rpm for 15 minutes to clear the lysate and the protein concentrations determined 
(Section 2.3.2). 
 
Alternatively, adherent cells were harvested by trypsinising with 0.05% trypsin-EDTA for 3 
minutes in a 37ºC incubator. After cells had lifted off the tissue culture dish/flask, trypsin was 
inactivated by the addition of appropriate cell media. Cells were pelleted at 1,200 rpm for 5 
minutes, resuspended in 0.15M saline to wash and centrifuged again at 1,200 rpm for 5 
minutes. Supernatant was removed and cells were resuspended in 400µl of UTB and 
transferred to 1.5ml microfuge tubes. Cells were sonicated and cleared as before.  
 
2.3.2 Protein Determination of Cell Lysates 
Protein concentrations of cell lysates were determined against a standard curve produced 
using known concentrations of bovine serum albumin (BSA) (Sigma). 5µl of cell lysate was 
diluted in 45µl of sterile distilled water, and 10µl of diluted cell lysate was added to one well 
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of a 96-well plate, repeated in quadruplet. 200µl of Bio-Rad Protein Reagent (Bio-Rad 
Laboratories) diluted 1:5 in sterile distilled water was added to each well and protein 
concentrations were read on a microplate reader (Bio-Rad model 680) at 595nm wavelength.  
 
2.3.3 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
20-50µl of cell lysate diluted in an equal volume of Laemmli sample buffer (25% v/v glycerol 
(BDH Laboratories), 5% β-mercaptoethanol, 2% w/v SDS (Severn Biotech), 0.01% w/v 
bromophenol blue (BDH Laboratories) and 65mM Tris (pH 6.8)). Samples were boiled at 
80ºC for 5 minutes, spun at 13,000 rpm for 1 minute and loaded, along with a molecular 
weight marker onto 6-12% polyacrylamide gels (30% w/v acrylamide (37:5:1 BIS-
acrylamide) (Severn Biotech), 0.1% SDS, 0.1M Tris/ 0.1M Bicine (Melford) (pH 8.3), 0.6% 
ammonium persulphate (APS) (Sigma) and 0.3% N,N,N’,N’,-
Tetramethylethylthylenediamine (TEMED) (Severn Biotech)). SDS-PAGE gels were run 
between 10-25mA, either overnight or through the day.  
 
2.3.4 Staining of Proteins on Nitrocellulose Membranes 
In order to visualise proteins transferred onto nitrocellulose membranes, membranes were 
stained with Ponceau-S stain containing 3% trichloroacetic acid (TCA) (BDH Laboratories) 
and 0.1% Ponceau-S (Sigma) for 30 seconds. Membranes were then washed in distilled water 
to remove residual Ponceau-S stain. Following visualisation of proteins, nitrocellulose 
membranes were washed in Tris-Buffered Saline Tween-80 (TBST) containing 0.15M NaCl 
(Sigma), 50mM Tris, 1% Tween-80 (Sigma) and HCl pH 7.4), until all Ponceau-S stain was 
removed from the membrane.  
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2.4 Immunological Techniques 
2.4.1 Western Blotting 
Proteins separated by SDS-PAGE were transferred onto nitrocellulose membranes using the 
following method. SDS-PAGE gels were inserted into a transfer cassette containing a sponge, 
one piece of Whatmann blotting paper, nitrocellulose membrane (Pall corporation), the SDS-
PAGE gel, another piece of Whatmann blotting paper and another sponge (all components 
within the transfer cassette were pre-immersed in transfer buffer). Transfer cassettes were 
placed in a transfer tank filled with pre-chilled transfer buffer (20% v/v methanol (Sigma), 
0.19M glycine (Melford) and 0.05M Tris), and left transferring at 200mA overnight (18 
hours). Following the transfer, nitrocellulose membranes were stained in Ponceau-S stain to 
visualise transferred proteins and assess for equal loading amongst the samples (Section 
2.3.4). Nitrocellulose membranes were then washed in TBST to remove the Ponceau-S stain 
and subsequently incubated in 5% w/v skimmed milk (Marvel) diluted in TBST or 5% w/v 
BSA (Sigma) in TBST for 30 minutes to block non-specific antibody binding to the 
nitrocellulose membrane. Primary antibodies (Table 2.2) were incubated with the 
nitrocellulose membrane by heat sealing in polythene bags, and left on a rocker at 4ºC 
overnight. Following overnight incubation, nitrocellulose membranes were washed in TBST 6 
times for 5 minutes each time. Nitrocellulose membranes were then incubated with the 
appropriate secondary antibody (Table 2.3) diluted in 5% w/v dried skimmed milk or 5% w/v 
BSA, and left on a rocker at room temperature for 2 hours. After 2 hours, nitrocellulose 
membranes were washed again in TBST, 6 times for 5 minutes each time. Nitrocellulose 
membranes were then incubated in enhanced chemiluminescence (ECL) (Millipore) for 1 
minute, sealed in saran wrap and exposed to autoradiography film (Kodak) to allow 
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visualisation of appropriate proteins. Typical exposure times varied from 10 seconds to 2 
hours.  
 
2.5 Statistical Techniques 
2.5.1 Paired, Two-Sided T-Test 
Two-sided, paired T-tests were conducted in order to determine whether the mean difference 
between two groups (typically treated against control samples) were statistically significant. 
All t-tests were performed at the 95% confidence interval, i.e. a p-value of 0.05 using 
GraphPad Prism software. 
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Table 2.2: Primary antibodies used throughout the duration of this study. The primary antibodies used 
throughout the duration of this study are indicated, as well as the antigen they target, dilution used, molecular 
weight, application, species and source.  
 
Antibody Antigen Dilution Size (kDa) Use Species Company/Source 
ATM ATM 1 in 500 350 WB Mouse Oncogene Research Products 
β-Actin β-Actin 1 in 10000 45 WB Mouse Sigma 
Chk1 Chk1 1 in 1000 56 WB Mouse Santa Cruz 
Chk2 Chk2 1 in 5000 62 WB Rabbit Professor Steve Elledge 
Histone H3 
(H2AX) H2AX 1 in 1000 15 WB Rabbit Cell Signaling  
KCP KCP 1 in 1000 60 WB Mouse In house 
LANA1 LANA1 1 in 500 222 WB Mouse Novacastra 
LANA1 LANA1 1 in 1000 222 WB Rat Advanced Biotechnologies 
NBS1 NBS1 1 in 1000 95 WB Mouse Abcam 
p-ATM Phospho-ATM 1 in 1000 350 WB Rabbit R&D Systems 
p-Chk1 Phospho-Chk1 1 in 1000 56 WB Rabbit Bethyl 
γH2AX γH2AX 1 in 1000 15 WB Mouse Millipore 
p-NBS1 Phospho-NBS1 1 in 500 95 WB Rabbit SAB 
p-RPA32 
Phospho-
RPA32 1 in 1000 32 WB Rabbit Bethyl 
p53 p53 1 in 100 53 WB Mouse Professor David Lane 
RPA32 RPA32 1 in 1000 32 WB Rabbit Abcam 
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Table 2.3: Secondary antibodies used in this study. The secondary antibodies used in this study 
are indicated, as well as the antigen they target, dilution used, species and source.  
 
Antibody Antigen Dilution Use Species Company/Source 
Mouse Mouse 1 in 2000 WB Goat Dako Laboratories 
Rabbit Rabbit 1 in 3000 WB Swine Dako Laboratories 
Rat Rat 1 in 1000 WB Rabbit Dako Laboratories 
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3.1 De novo KSHV Infection Activates Components of the DNA Damage Response 
In order to determine the effects of de novo KSHV infection on components of the DNA 
damage response, Ad5E1HEK293 cells were infected with a recombinant KSHV, 
vKSHV.219, which constitutively expresses GFP under the control of a EF-1a promoter and 
RFP under the control of a lytic PAN promoter (Vieira and O’Hearn, 2004). Ad5E1HEK293 
cells were infected with vKSHV.219 and since infected and lytically replicating cells express 
GFP and RFP respectively, infection and reactivation was confirmed by fluorescence 
microscopy. Ad5E1HEK293 cells were analysed for GFP and RFP expression by 
fluorescence microscopy at 0, 8, 24, 48, 72 and 96 hours post-infection, with uninfected 
control Ad5E1HEK293 cells in parallel. Microscopy images showed Ad5E1HEK293 cells 
were latently infected with vKSHV.219 as early as 8 hours post-infection, with a small 
number of infected cells undergoing lytic replication by 24 hours post-infection (Figure 
3.1A). 
  
In addition to visualisation of KSHV infection by fluorescence microscopy, the percentage of 
infected Ad5E1HEK293 cells was quantified by flow cytometry. Approximately 100,000 
cells were harvested, fixed and analysed for GFP expression. Figure 3.1B shows a typical 
GFP expression pattern following recombinant KSHV infection. At 8 hours post-infection, 
approximately 37% of live Ad5E1HEK293 cells were latently infected with KSHV, by 24 
hours post-infection, approximately 81% of live Ad5E1HEK293 cells were latently infected 
with vKSHV.219 virus. Following 48, 72 and 96 hours post-infection, the percentage of 
Ad5E1HEK293 cells latently infected with KSHV gradually decreased to 49%, 39% and  
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Figure 3.1: Validation of KSHV Infectivity in Ad5E1HEK293 Cells. Ad5E1HEK293 
cells were infected  with a recombinant KSHV (vKSHV.219) that expresses GFP under 
the control of a constitutively active promoter, and RFP under the control of a KSHV 
lytic promoter. A. Following 0, 8, 24, 48, 72 and 96 hours post-KSHV infection, cells 
were examined  by fluorescence microscopy to confirm both latent (GFP) and lytic (RFP) 
infection. B. Quantification of  KSHV infectivity was achieved by flow cytometry to 
measure the percentage of cells expressing GFP in infected Ad5E1HEK293 cells against 
uninfected controls. C. The percentage of infected Ad5E1HEK293 cells expressing GFP 
against uninfected controls are indicated. These data are representative of one experiment 
performed twice. 
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Figure 3.2: De novo KSHV Infection Activates Components of the DNA 
Damage Response. Ad5E1HEK293 cells were infected with a recombinant KSHV 
(vKSHV.219) and harvested at 0, 8, 24, 48, 72 and 96 hours post-infection with 
uninfected control cells in parallel. Lysates were subjected to Western blotting for a 
number of representative DNA damage response proteins, KSHV latent (LANA) 
and lytic (KCP) proteins as controls, and β-Actin used as a loading control. UV and 
IR treated samples were included as a control to verify phospho-antibodies were 
working. These data are representative of one experiment performed twice. 
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36%, respectively, probably due to the proliferation of uninfected cells (Figure 3.1B and 
3.1C).  
 
Infected Ad5E1HEK293 cells, along with uninfected controls, were harvested at 0, 8, 24, 48, 
72 and 96 hours post-infection and lysates were subjected to Western blotting for a number of 
representative DNA damage response proteins. In addition, KSHV latent (LANA) and lytic 
(KCP) proteins were immuno-blotted as controls, and β-Actin used as a loading control. IR 
and UV samples were loaded to verify that the phospho-antibodies were working. The latent 
KSHV protein LANA was detected at 24 hours post-infection, confirming previous 
microscopy and flow cytometry data demonstrating successful infection (Figure 3.1). The 
lytic KSHV protein KCP remained undetected throughout the course of KSHV infection 
(Figure 3.2), probably owing to the fact that only a small number of infected cells were 
undergoing lytic replication (Figure 3.1A). Total protein levels of the DNA damage proteins 
ATM, NBS1, Chk1, Chk2, p53, RPA, H2AX remained unchanged throughout the course of 
KSHV infection when compared to uninfected controls (Figure 3.2). Phosphorylation of Chk2 
remained unchanged when compared to uninfected control samples. Phosphorylation of 
ATM, NBS1, Chk1, RPA and H2AX increased in the later stages of KSHV infection, 
suggesting the infected cells respond to KSHV infection by activation of the DNA damage 
response (Figure 3.2). 
 
3.2 KSHV Reactivation of Lytic KSHV Replication Activates Components of the ATM 
and ATR DNA Damage Signalling Pathways 
In order to assess the effect of reactivation of KSHV lytic replication on components of the 
DNA damage response, we used the VK219 cell line, latently infected with vKSHV.219  
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Figure 3.3 KSHV Reactivation of Lytic Replication Activates Components of 
the DNA Damage Response. VK219 cells latently infected with vKSHV.219 virus 
were reactivated using a baculovirus which expresses the KSHV lytic switch 
protein RTA. A. Reactivated cells, and unreactivated controls were analysed by 
fluorescence microscopy at 0, 4, 8, 16, 24 and 48 hours post-reactivation to assess 
levels of reactivation. B. Both reactivated and unreactivated control cells were 
harvested at 0, 4, 8, 16, 24 and 48 hours post-reactivation and analysed by Western 
blotting for a panel of representative DNA damage response proteins, KSHV latent 
(LANA) and lytic (KCP) proteins as controls, and β-Actin used as a loading 
control. These data are representative of one experiment repeated 3 times 
independently. 
KCP 
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virus. Using Back50 which expresses the lytic switch protein RTA under the control of a 
HCMV promoter, we induced lytic KSHV replication in these cells, which was assessed by 
observing RFP expression by fluorescence microscopy. A small number of infected cells were 
lytically replicating after approximately 16 hours post-reactivation, and, by 48 hours, 
approximately 100% of infected cells had become lytic (Figure 3.3A). Reactivated cells, with 
untreated controls in parallel, were harvested at 0, 4, 8, 16, 24 and 48 hours post-reactivation 
and subjected to Western blotting for a panel of DNA damage proteins along with KSHV 
latent (LANA) and lytic (KCP) proteins as controls, and β-Actin as a loading control. LANA 
was detected in all untreated and reactivated samples, confirming the cells were latently 
infected with KSHV. Protein levels of KCP increased at approximately 16 hours post-
reactivation, showing successful reactivation of latently infected Vero cells. Total protein 
levels of the DNA damage response proteins ATM, NBS1, Chk1, Chk2, p53, RPA and H2AX 
remained unchanged during reactivation into the lytic KSHV phase. No phosphorylated NBS1 
or Chk1 was detected throughout the course of infection (immuno-blotted at the same time as 
results obtained in Figure 3.2 so antibodies were confirmed as working). Levels of p-ATM, p-
Chk2, p-RPA and γH2AX increased during reactivation, suggesting that the lytic phase causes 
host cells to activate components of both the ATM and ATR DNA damage signalling 
pathways (Figure 3.3B). 
 
3.3 Inhibition of ATM/ATR DNA Damage Signalling Pathways by Caffeine Treatment 
Increases KSHV Infectivity of Ad5E1HEK293 Cells.  
In order to assess whether the ATM/ATR DNA damage signalling pathways are required for 
KSHV infectivity, Ad5E1HEK293 cells were infected vKSHV.219 virus and inoculated 
Ad5E1HEK293 cells were treated with caffeine, a broad-range ATM/ATR kinase inhibitor 
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(Sarkaria et al., 1999). Infection was confirmed by visualisation of GFP by fluorescence 
microscopy (data not shown), and the extent of infection was quantified by measuring GFP 
expression by flow cytometry. Cells were analysed at 0, 8, 24, 48, 72 and 96 hours post-
infection, with inoculated, untreated Ad5E1HEK293 cells as controls in parallel. At 0 hours 
post-infection, 0.3% of infected control cells (not treated with caffeine) expressed GFP, and 
0.4% of infected caffeine-treated cells were expressing GFP, which was accepted as 
background fluorescence. At 8 hours post-infection, infected cells treated with caffeine were 
28.6% GFP positive, compared with 20.8% in infected, untreated controls. At 24 hours post-
infection, 62.0% of caffeine-treated infected cells were GFP positive, compared to 51.2% 
GFP positive in untreated control cells. A comparable difference in GFP expression was 
observed at 48, 72 and 96 hours post-infection (Figure 3.4A, B and C).  
 
In addition, caffeine-treated KSHV infected cells, along with untreated, infected controls were 
harvested 0, 8, 24, 48, 72 and 96 hours post-infection/treatment and subjected to Western 
blotting for γH2AX to assess efficiency of ATM/ATR inhibition, and β-Actin as a loading 
control. A decrease in γH2AX was observed 96 hours post-infection in cells treated with 
caffeine when compared to untreated controls, suggesting ATM/ATR pathways had been 
compromised (Figure 3.4D). To assess whether these results were reproducible, and whether 
the percentage difference in GFP expression observed between caffeine treated and untreated 
infected cells were statistically significant, the experiment was repeated twice more, results 
pooled and two-sided paired t-tests conducted. Similar percentage changes in GFP expression 
were observed between 8, 24, 48, 72 and 96 hours post-infection/treatment, with those cells 
treated with caffeine having approximately 10% or more GFP expression was observed 
compared to untreated controls. Statistically significant differences at the 95% confidence 
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96hr 22.3 38.7 16.4 
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Figure 3.4: Inhibition of ATM/ATR DNA Damage Signalling Pathways by Caffeine 
Treatment Increases KSHV Infectivity in Ad5E1HEK293 Cells. Ad5E1HEK293 cells 
were infected with vKSHV.291 virus and treated with the ATM/ATR inhibitor caffeine. A. 
At 0, 8, 24, 48, 72 and 96 hours post-infection/treatment, cells were harvested and subjected 
to flow cytometric analysis to determine the percentage of GFP expressing (i.e. percentage 
of KSHV infected) cells. B. The percentage of caffeine-treated, infected cells expressing 
GFP compared to untreated, infected controls. C. The percentage change in GFP expression 
of caffeine-treated, infected cells expressing GFP against untreated, infected controls. D. 
Caffeine-treated, infected cells were harvested, along with untreated infected cells at 0, 8, 
24, 48, 72 and 96 hours post-infection and analysed by Western blotting for γH2AX to 
assess efficiency of ATM/ATR inhibition and β-actin as a loading control. These data 
represent one experiment repeated twice. 
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48hr  - 41.8 7.8 4.5 
+ 56.4 10.2 5.9 2 0.0085 10.808 Yes 
72hr - 33.0 9.7 5.6 
+ 48.1 3.6 2.1 2 0.1046 2.8435 No 
96hr  - 31.5 7.9 4.6 
+ 41.1 4.9 2.8 2 0.1401 2.3828 No 
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Figure 3.4 Continued: Inhibition of ATM/ATR DNA Damage Signalling Pathways by 
Caffeine Treatment Increases KSHV Infectivity in Ad5E1HEK293 Cells. Ad5E1HEK293 
cells were infected vKSHV.219 virus and treated with the ATM/ATR inhibitor caffeine. At 0, 8, 
24, 48, 72 and 96 hours post-infection, cells were harvested and subjected to flow cytometric 
analysis to determine the percentage of GFP expressing, i.e. percentage of KSHV infected cells. 
E. The experiment was repeated three times to confirm the results shown were reproducible. 
Error bars shown represent standard deviation. F. Statistical analysis of the change in 
percentage GFP expression between KSHV-infected cells treated with caffeine against 
untreated controls.  
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interval were observed at 24 hours and 48 hours post-infection/treatment (Figure 3.4E and 
3.4F). 
 
3.4 Inhibition of the ATM/ATR DNA Damage Signalling Pathways by Caffeine 
Treatment Inhibits Reactivation of KSHV in Latently Infected Vero Cells.  
In order to determine whether the ATM/ATR DNA damage signalling pathways are important 
during reactivation of KSHV lytic replication, VK219 cells were reactivated by treating with 
Back50. Following treatment with Back50, cells were treated with caffeine to inhibit the 
ATM/ATR kinases. Caffeine-treated KSHV infected cells, with untreated, reactivated 
controls in parallel, were harvested at 0, 4, 8, 16, 24 and 48 hours post-reactivation/treatment 
and subjected to Western blotting for γH2AX to assess efficiency of ATM/ATR inhibition, 
and β-Actin as a loading control. A decrease in γH2AX was observed from 16 hours post-
reactivation in cells treated with caffeine when compared to untreated controls, suggesting 
ATM/ATR pathways have been compromised (Figure 3.5A). 
 
Following reactivation and caffeine treatment, infected Vero cells were analysed for evidence 
of lytic KSHV replication, with reactivated, untreated control cells in parallel, by observing 
RFP expression by fluorescence microscopy. Analysis of microscopy images showed cells 
that were treated with caffeine exhibited less RFP expression, suggesting lower levels of 
reactivation (Figure 3.5B). In order to confirm this observation quantitatively, 10 fields of 
cells were counted at 0, 4, 8, 16, 24 and 48 hours post-reactivation and caffeine treatment, 
with untreated, reactivated infected cells in parallel as controls. The number of GFP and RFP 
positive cells in each field was counted and the percentage of reactivated cells calculated. No 
reactivated cells were observed at 0, 4 and 8 hours post-reactivation, in either the control or 
0h
r 
4h
r 
8h
r 
16
hr
 
24
hr
 
48
hr
 
Reactivated 
0h
r 
4h
r 
8h
r 
16
hr
 
24
hr
 
48
hr
 
Reactivated + caffeine 
Total cells Total cells Latent Latent Lytic Lytic 
Figure 3.5: Inhibition of the ATM/ATR DNA Damage Signalling Pathways by 
Caffeine Treatment Inhibits Reactivation of KSHV in VK219 Cells. VK219 cells 
latently infected with vKSHV.219 virus were reactivated using a baculovirus with 
expresses the KSHV lytic switch protein RTA. Reactivated cells were treated with 
caffeine, with untreated, reactivated VK219 cells as controls. A. Caffeine-treated, 
reactivated cells were harvested, with untreated reactivated VK219 cells at 0, 4, 8, 16, 24 
and 48 hours post-reactivation and analysed by Western blotting. B. Following 
treatment, reactivated, VK219 cells were examined by fluorescence microscopy to 
assess for reactivation against untreated, reactivated controls. These data are 
representative of one experiment performed twice. 
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Mean % RFP 
expression SD SEM df P value t  value 
Statistical  
significance 
0hr - 0 N/A N/A 
+ 0 N/A N/A N/A N/A N/A N/A 
4hr - 0 N/A N/A 
+ 0 N/A N/A N/A N/A N/A N/A 
8hr - 0 N/A N/A 
+ 0 N/A N/A N/A N/A N/A N/A 
16hr  - 53.8 2.9 0.9 
+ 33.6 4.1 1.3 9 0.0001 21.7541 Yes 
24hr - 76.4 4.9 1.5 
+ 36.3 5.0 1.6 9 0.0001 17.2668 Yes 
48hr  - 95.4 3.2 1.0 
+ 59.5 4.7 1.5 9 0.0001 32.8964 Yes 
Figure 3.5 Continued: Inhibition of the ATM/ATR DNA Damage Signalling 
Pathways by Caffeine Treatment Inhibits Reactivation of KSHV in VK219 Cells. 
VK219 cells latently infected with vKSHV.219 virus were reactivated using a 
baculovirus which expresses the KSHV lytic switch protein RTA. Reactivated cells 
were treated with caffeine, with untreated, reactivated VK219 cells as controls. In 
addition to assessing reactivation levels using fluorescence microscopy, following 
treatment, reactivated, VK219 cells were examined by counting the number of GFP and 
RFP positive cells in ten fields at 0, 4, 8, 16, 24 and 48 hours post-reactivation, and 
from this working out the percentage of reactivated cells. C. Collated results from ten 
counted fields are shown, with error bars denoting standard deviation. D. t tests were 
conducted to determine whether the differences in percentage reactivation between 
treated and non treated reactivated cells were statistically significant. t tests were 
conducted at the 95% confidence interval. These data are representative of one 
experiment performed twice. 
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the caffeine treated samples. On average, at 16 hours post-reactivation, 33.6% of cells latently 
infected with recombinant KSHV had become lytic in those cells treated with caffeine, 
compared with 53.8% of cells becoming lytic in control cells. Following 24 hours 
reactivation, 36.3% of latently infected Vero cells had become lytic when treated with 
caffeine, compared to 76.4% lytic cells in the controls. At 48 hours post-reactivation, 59.5% 
of caffeine treated, latently infected Vero cells were lytic, whilst 95.4% of latently infected 
Vero cells were lytic in the untreated controls. The percentage differences in reactivation 
between caffeine treated and untreated latently infected cells at 16, 24 and 48 hours post-
reactivation were all considered to be statistically significant at the 95% confidence interval 
(Figure 3.5C and D).  
 
3.5 Lytic KSHV Replication Inhibits the DNA Damage Response in Response to Ultra-
Violet Radiation 
To establish whether cells infected with KSHV respond differently to DNA damage compared 
to uninfected controls, uninfected Vero cells, VK219 cells (latently infected with KSHV) and 
VK219 cells which had been reactivated to induce lytic KSHV replication 24 hours 
previously, were exposed to 20JM
-2
 of UV radiation to induce ssDNA breaks. Cells were 
harvested at 0, 1, 2, 4, 8, and 24 hours following UV radiation and subjected to Western 
blotting for p53, LANA (infection control), KCP (lytic infection control) and β-Actin (loading 
control). In response to UV radiation, VK219 cells (latently infected with KSHV) induced 
p53 expression in a similar manner to control uninfected Vero cells. However, in reactivated 
VK219 cells, the induction of p53 was repressed (Figure 3.6). 
 
 
0h
r 
1h
r 
2h
r 
4h
r 
8h
r 
24
hr
 
Uninfected Vero 
β-Actin 
LANA 
KCP 
0h
r 
1h
r 
2h
r 
8h
r 
VK219 Latent 
4h
r 
24
hr
 
0h
r 
1h
r 
2h
r 
8h
r 
VK219 Lytic 
4h
r 
24
hr
 
p53 
Hours post-UV: 
Figure 3.6: Lytic KSHV Replication Inhibits the DNA Damage Response in Response 
to Ultra-Violet Radiation. Uninfected Vero cells, VK219 cells latently infected with 
KSHV and reactivated VK219 cells were exposed to 20JM-2  UV radiation. Cells were 
harvested at 0, 1, 2, 4, 8 and 24 hours post-UV exposure and analysed by Western blotting 
for p53, LANA, KCP and β-Actin. These data are representative of one experiment 
performed twice. 
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3.6 Latent KSHV Infection Induces the DNA Damage Response in Response to Ionising 
Radiation 
To determine whether cells infected with KSHV respond differently to different forms of 
DNA damage, the response to IR inducing double-strand breaks of uninfected Vero cells, 
VK219 cells (latently infected with KSHV) infected cells, and VK219 cells which had been 
reactivated to induce lytic KSHV replication 24 hours previously were examined. Cells were 
exposed to IR and harvested at 0, 1, 2, 4, 8 and 24 hours post-IR and subjected to Western 
blotting for p53, LANA (infection control), KCP (lytic infection control) and β-Actin (loading 
control). In response to IR, VK219 cells (latently infected with KSHV) induce p53 protein 
levels to a greater extent than uninfected control Vero cells. Reactivated VK219 cells had a 
similar response to IR as uninfected control Vero cells (Figure 3.7). 
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Figure 3.7: Latent KSHV infection Induces the DNA Damage Response in Response 
to Ionising Radiation. Uninfected Vero cells, VK219 cells latently infected with KSHV 
and reactivated VK219 cells were exposed to IR. Cells were harvested at 0, 1, 2, 4, 8 and 
24 hours post-IR exposure and analysed by Western blotting for p53, LANA, KCP and 
β-Actin. These data are representative of one experiment performed twice. 
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4. Discussion 
At the beginning of this study, the relationship of KSHV infection with the DNA damage 
response was incompletely understood. A number of publications had suggested that KSHV 
proteins are able to interact (although not necessarily physically), with components of the 
DNA damage responses. For example, vIRF1 was shown to inhibit ATM and p53 activity in 
order to promote viral replication in infected cells, whilst vCyclin was shown to activate 
ATM, H2AX and Chk2 (Shin et al., 2006; Koopal et al., 2007). Further evidence for a role of 
KSHV and the DNA damage response came from studies of the related murine gamma-
herpesvirus, MHV68. Studies on this virus showed that the viral protein, orf36, was able to 
directly phosphorylate H2AX, and interestingly the effect was to promote viral replication 
(Tarakanova et al., 2007). Other related herpesviruses, including HSV1, CMV and EBV have 
all been previously shown to interact with cellular DNA damage response proteins, another 
indication that KSHV may have a close relationship with components of the DNA damage 
response (Section 1.5).  
 
The principle aim of this study was elucidate the relationship between KSHV infection and 
the cellular DNA damage response. Therefore the first objective of this study was to 
determine the effects of de novo KSHV infection on components of the cellular DNA damage 
response (Objective 1, Section 1.6). Generally it is believed that oncogenic viruses are able to 
either inhibit or activate the cellular DNA damage response. In some cases, viral genomes are 
recognised as ‘broken cellular DNA’ and as a result, are targeted by the cellular DNA damage 
response. In order to prevent this, some viruses have evolved complex mechanisms to 
circumvent, or inhibit, the DNA damage response (Lilley et al., 2007). Mechanisms of 
inhibition usually include mislocalisation of DNA damage proteins away from sites of 
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damage, or degradation of the damage proteins themselves. This is certainly the case for 
adenovirus, where the adenoviral E4orf3 protein is able to mislocalise Mre11 away from viral 
replication centres, and the adenoviral E4orf6/E1B55K complex targets a number of DNA 
damage proteins for degradation (Weitzman and Ornelles, 2005). In other cases, viruses, such 
as EBV, exploit the cellular DNA damage response. A number of mismatch repair proteins 
including MSH-2, MSH-6 and MLH1 are assembled into viral replication centres during EBV 
infection, presumably to correct any mismatches in replicated viral DNA (Daikoku et al., 
2006). Work presented in this study shows that de novo KSHV infection of Ad5E1HEK293 
cells is able to activate components of the DNA damage response. We observed an increase in 
phosphorylation of ATM, NBS1, Chk1, RPA and H2AX in KSHV infected Ad5E1HEK293 
cells when compared to uninfected controls (Figure 3.2). To our knowledge, this is the first 
report to suggest that de novo KSHV infection is able to activate components of the DNA 
damage response.  The work presented here is consistent with the study by Koopal et al who 
suggested that the KSHV viral protein vCyclin can activate the phosphorylation of ATM, 
H2AX and Chk2 (Koopal et al., 2007). Reactivation of cells latently infected with KSHV also 
activated the cellular DNA damage response as determined by phosphorylation of ATM, 
Chk2, RPA and H2AX (Figure 3.3) (Objective 2, Section 1.6). Interestingly, activation of 
ATM, Chk2 and H2AX was also observed during lytic replication of the related EBV (Nikitin 
et al., 2010). The reason why the cellular DNA damage response is induced post-KSHV 
infection is unclear at present. The possibility that the viral genome is recognised as ‘broken 
DNA ends’ (as in adenovirus infection) is unlikely since the KSHV genome is circularised 
almost immediately upon infection, and DNA damage responses were not activated until 
approximately 72 hours post-KSHV infection (Figure 3.2). Instead, we speculate that the host 
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cell may respond to the production of viral protein, and responding to cellular stress, induce a 
cellular DNA damage response.  
 
The next objective of this study was to establish whether KSHV uses the cellular DNA 
damage response to aid infection of the host cell (Objective 3, Section 1.6). In response to 
treatment with the broad-spectrum ATM/ATR inhibitor caffeine, we observed a statistically 
significant increase in KSHV infectivity during the early stages of infection (24-48 hours 
post-infection) when compared to untreated controls (Figure 3.4). In contrast to the previous 
result suggesting that activation of the cellular DNA damage response may be important 
during KSHV infection, this suggests that abrogated ATM/ATR signalling pathways are 
beneficial for KSHV infectivity.  Curiously, there was a statistically significant decrease in 
the percentage of lytically replicating KSHV infected cells when compared to untreated 
controls, suggesting that KSHV requires the cellular DNA damage pathways intact during 
lytic replication (Figure 3.5). 
 
Recently, it has become apparent that a single virus is able to both activate and inhibit 
components of the DNA damage response, revealing a more complex relationship between 
viruses and the cellular response to DNA damage. In the context of herpesviruses, HSV1 is an 
example of a virus which is able to both activate and inhibit components of the response 
pathway. HSV1 infection induces a DNA damage response, activating ATM and downstream 
targets such as Nbs1, Chk2 and p53 (Shirata et al., 2005). In addition, HSV1 infection induces 
the cellular activation of RPA (Wilkinson and Weller, 2004). Interestingly, HSV1 appears to 
be able to inhibit ATR activity through its association with, and sequestering of, 
phosphorylated RPA and ATRIP. It is thought that the viral protein ICP0 is responsible for 
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sequestering ATRIP, preventing downstream activation of ATR targets (Wilkinson and 
Weller, 2006). In addition, the HSV-1 protein, Vmw100, is thought to induce proteasomal 
degradation of the NHEJ repair protein DNA-PKCS (Parkinson et al., 1999). In the case of the 
murine herpesvirus, MHV68, the M2 protein is able to activate ATM and induce the 
localisation of the DDB1/COP9/cullin DNA repair complex to the nucleus in the absence of 
DNA damage. In response to DNA damage, the MRN complex is not recruited to the sites of 
damage, and H2AX remains unphosphorylated, preventing apoptosis of the infected cell 
(Liang et al., 2006). HCMV infection induces cellular activation of ATM, H2AX, Chk2 and 
p53. However, a number of DNA damage proteins, including ATM, Chk2 and Ku proteins 
(involved in NHEJ repair), are sequestered away from viral replication centres, suggesting 
that some components of the DNA damage response are required to be inhibited for the virus 
to replicate effectively (Luo et al., 2007; Gaspar and Shenk., 2005).  
 
The relatively novel idea that oncogenic viruses are able to both inhibit and activate the 
cellular DNA damage response is interesting in light of the results obtained in this study. In 
the case of KSHV infection, it is already known that the vCyclin can induce the cellular DNA 
damage response, causing activation and phosphorylation of ATM, H2AX and Chk2. In 
addition, vIRF1 is believed to inhibit the activity of ATM and p53 (Shin et al., 2006). Taken 
together, these data suggests that KSHV has a dual role as both an activator and inhibitor of 
the cellular DNA damage response. Indeed, data presented in this study supports this concept, 
since de novo KSHV infection is able to induce the activation of the damage response and yet, 
inhibition of ATM activity appears to increase KSHV infectivity (Figure 3.2 and Figure 3.4). 
Following initial activation of the damage response, possibly by detection of viral RNA or 
protein, KSHV proteins (such as vIRF1) may then inhibit certain components of the DNA 
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damage pathways, whether by direct interaction (vIRF1 and ATM), proteasome-mediated 
degradation (vIRF1 and p53), or by mislocalisation away from the sites of DNA damage (as is 
the case with other herpesviruses such as HSV1, MVH68 and HCMV). Elimination of 
components of the cellular DNA damage response, in this context, may be beneficial for 
KSHV in order to effectively replicate and avoid host cell surveillance and subsequent 
apoptosis.  
 
The final objective of this study was to determine the capacity of KSHV to modulate the 
DNA damage response to mutagenic treatments (Objective 4, Section 1.6). In response to UV 
radiation, lytically-replicating KSHV-infected cells inhibited the normal DNA damage 
response observed in uninfected control cells (Figure 3.6). Since this was observed after UV 
radiation, we speculate that KSHV targets components of the ATR signalling pathway, 
possibly by direct targeting, degradation or mislocalisation, thereby inhibiting the cellular 
DNA damage response and in turn preventing apoptosis of the infected cell. Indeed, during 
MHV68 infection, the MRN complex is not relocalised to sites of DNA damage in response 
to DNA damaging agents (Liang et al., 2006). Further investigation will determine whether 
the same can be said for KSHV infection. In addition, in response to IR, cells latently infected 
with KSHV induced the cellular DNA damage response to a greater extent than observed in 
control, uninfected cells (Figure 3.7). This perhaps suggesting that KSHV may use the 
cellular DNA damage response, or more specifically components of the ATM pathway, to 
effectively replicate in the host.  
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4.1 Limitations 
One issue throughout the duration of this project was the use of the Ad5E1HEK293 cell line 
as a target for infection with KSHV. Since the Ad5E1HEK293 cell line is virally transformed 
using the Adenovirus E1 proteins, it is not surprising we observed a small degree of 
phosphorylation of DNA damage proteins in the uninfected, control cells. Unfortunately the 
Ad5E1HEK293 cell line is the most readily infectable with KSHV; our laboratory has 
previously attempted to infect HeLas (this proved difficult without using high titres of virus) 
and primary human umbilical vein endothelial cells (HUVECs), which are notoriously 
difficult to infect. Another limitation in this study was in obtaining sufficient recombinant 
KSHV. Each virus preparation produced a relatively low virus titre, meaning that it was 
difficult to repeat the caffeine infectivity assay in triplicate. As a result, different virus 
preparations were used to repeat the experiment, resulting in large variations between 
experiments which masked statistical significance (Figure 3.4 and 3.5). Finally, the use of the 
ATM/ATR inhibitor caffeine is relatively non-specific and is known to inhibit other kinases, 
therefore the results obtained in this study may not only be due to the inhibition of ATM and 
ATR. 
 
4.2 Future Work 
To circumvent the limitations of this study, it would be beneficial to infect with recombinant 
KSHV in a number of different cells lines in order to confirm the activation of the cellular 
DNA damage response in response to KSHV infection. In addition, we would like to prepare 
larger virus preparations, to produce enough virus so that the caffeine infectivity assay could 
be run in triplicate. Furthermore, it would be advantageous to use specific inhibitors of ATM 
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and ATR to assess whether the results obtained in this study are due to the inhibition of these 
kinases or due to caffeine’s non-specific inhibition of other kinases.   
 
To follow on from this project, it would be interesting to assess, via immuno-fluorescence 
microscopy, whether DNA damage proteins localise to viral replication centres during de 
novo infection and reactivation, and whether any damage proteins are mislocalised away from 
these centres (such is the case for other herpesviruses). These results would give a clearer 
indication of the role of the cellular DNA damage response during KSHV infection and 
reactivation. In addition, it would be interesting to determine by siRNA interference against 
viral proteins such as vIRF1 and vCyclin, whether activation of the cellular DNA damage 
response remains the same in the absence of these viral proteins.  
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